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PREFACE

In this monoi:i:raph I have attempted a survey of' the
literature pertaining to all of' the drugs which have
been used by the intravenous route, for the production
of anesthesia.

Some of the drugs represent old and out-

moded methods, while others repTesent the newest and the
most recent discoveries resulting from the endless search
for a perfect anesthetic agent.

However, for the sake of

completeness, each drug will be discussed as fully as the
time permits, with as few as possible remarks concerning
the efficacy or inefficacy of that particular method as
compared to methods of administration other than intravenous administration.

1

INTRODUCTION

The field of intravenous anesthesia has been, from
the beginning, and still is, one of the most bitterly
contested points in medical literature.

It presents re-

nown scientists championing its cause, and hosts of equally brilliant men who denounce it with sincerity.

It is

the purpose of this paper to only give the opinlons, both
pro and con, upon this controversial subject, and not to
endeavor to decide the issue.

The bitter fight between

those advocating the inhalation route, Bnd those upholding
the intravenous methods, will be

~iven

in a fair and im-

partial attitude by the writer, and if a verdict is to be
rendered in favor of either, it is left to the reader's
discretion to do so.
I am including a brief chapter on the history, describing the evolution of anesthesia, in general, in order to
more clearly and logically show the reader the nreliminary
step by step progress that science has undergone in its
search for the perfect anesthesia,- the utopia of anesthetists.

Intravenous nnesthesia, as other anesthesia, has its

good and bad points, and a definite place in anesthesia.
Perhaps it is best to place its choice wj.th the surgeon.
That evidence which gives the surrr,eon the most peace of
mind, knowing his patient's condition as he should, will
decide its applicability in each instance.
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HISTORY

"And the Lord God caused a deep sleep to fall upon
Adam, and he slept; and He took one of his ribs and closed up the flesh instead thereof".

It has been claimed that

in the "deep sleep" which the Creator "caused to fall upon
Adsmt1 , is the germ of the idea of anesthesia that has come
down to us from the dim ages of the past.

It is probable

that primitive man used digital compression of the carotid
arteries to produce anesthesia, as the inhabitants of some
countries do today.

This method.was practiced by the race

of Assyrians before performing the operation of circumcision.

Curiously too, the literal translation of the Greek

and Russian terms for the carotid is "the artery of sleep".
( 108)

The ancient Egyptians are believed to have used Indian
hemp and the juice of the poppy to cause a uatient to become drowsy before a surgical operation.

Pliny (108) re-

lates, that they applied to painful wounds a species of
rock brought from Memphis, which was powdered and moistened with sour wine.

This is the first record of local an-

esthesia with carbonic gas.

It is probable that the "wine

mingled with myrrh", which, according to St. Mark, was
offered to Christ before he was nailed upon the cross, was
indeed a narcotic draught, given with the object of lessening his sensibility to the agony that was forth-coming from
his persecutors.

The earliest reference to anesthesia by inhalation
is contained in the works of Herodatus, who states that
the Scythians were accustomed to produce intoxication by
inhaling the vapor of a certain kind of hemp which they
t.hrew upon the fire.

This was probably cannabis indicus,

or Indian hemp.
During the fifteenth century, several new drugs had
been introduced and used as an inhalation, in mixed form.
The following is the composition of the sleeping sponge,
and the method used.

"Take of onium, of the juice of the

forest mulberry, of the seeds of lettuce, of the seeds of
dock, which has large round apples, and of the water-hemlock, each an ounce.

Mix all these in a vessel, and then

place it in a new sponge; let the whole boil until the
sponge consumes it all.

Place the sponge in hot water for

an hour and let it be applied to the nostrils of him who
is to fall asleep".

The sleep produced was so profound

it often continued for several days. (108)
Local anesthesia was not unknown during the middle
ages, snd Cardow recommends the inunction of a mixture
consisting of opium, celandini, together with oils.

Now

crushed seeds of poppy and henbane were applied as a
plaster to parts about to be cauterized.
was also produced by freezing.

Local anesthesia

During the seventeenth

and eighteenth centuries the interest in anesthesia began
to wane and few allusions are made to it until late in the
eighteenth century.

Thus, from the dawn of creation, an

r-··~·····
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anesthesia for surgical operations had been prActiced to
some extent, but, owing to the uncertainty of rhe potency
and action of the powerful narcotics and palliatives administered and the

dan~er

attendinp, their use when exact

science was unknown, the practice seemed likely to fall
into oblivion.

At last a series of brilliant discoveries

in chemistry created a new epoch in the history of anesthesia.
The chemical era of anesthesia brought about the discoveries of Priestley about 1767.
of Rdmini stering

~ases

through the lungs.

These led up to the plan

and vapors of deflni te cor·,o(-,:;::·i t.ton

In course of time, nitrous ox:i de, ·:hich

hnd been discovered by Priestley in 1776, was introduced by
Humphery Davy as an inhalant, and he discovered to his great
delight that it relieved pain.

About this time, Professor

Thompson of Glasgow was accustomed to amuse his students
annually by allowing them to inhale ether and nitrous oxide
until they were intoxicated.

It is an extraordinary fact

that, even in the face of such experiments, no one among
the investigators who stood at this ttme on the brink of so
great a discovery ventured over the threshold.

The things

that are the most apparent may be the longest buried, and
so with the discovery of efficient anesthesia. (109)
In 1844, however, Dr. Colton, a pupil under Turner of
London, delivered a lecture at Hartford, Connecticut.

Some

demonstrations for the amusement of the audience were done.
Dr. Wells who was in the audience induced a Dr. Riggs to be

5.

the operator and extract a tooth while under the influence
of the nitrous oxide.
without pain.

This was done and, as Wells stated,

Wells then demonstrated its use several

succeeding times.

He was asked to address a class at the

Massachusetts General Hosnital, at which time his experiment was not successful, and the whole thing was denounced as humbug.

He became disappointed, his death occuring

&Je to this, at thirty-two.

To Wells, however, belongs the

credit for having first shown the practicability of producing insensibility b;r the use of nitrous oxide and establishing the principle of anesthesia.
In 1828,

Far~day

had called attention to the anesth-

etic properties of ether.

In 1839, Clarke and Morton be-

gan amusing their friends by the use of ether, just as
nitrous oxide was first used.

Morton began studying the

more serious side of the unconsciousness brought on by ether,
and finding his conclusions similar to those of Wells, he
had the opportunity to use ether on several extractions.
These proved to be very successful and he obtained permissionto test his new anesthetic on a surgical patient at the
Massachusetts General Hospital.

The operation was a big

success and soon after (1846) a meeting was held in Boston
to decide on a name for the "sleep producing" substance.
Morton himself chose the name "letheon", but subsequently
Dr. Oliver Wendell Holmes suggested "anesthesia" for the
condition, and the word "anesthetic" for the ap:ent.

These

were immediately taken up by the profession and laity.

----

------

---
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Chloroform as a substance h&d been known for some time.
It also passed through a series of more or less amusing experiments, before Waldie and Simpson became aware of its
practical uses.

In 1847, Simpson first used chloroform an-

esthesia with success and reported the same to the MedicoChrurgical Society of Edinburgh.

The advent of chloroform

gave an impetus to other investigators, and during the last
fifty years such aryents as ethyl chloride, ethyl bromide,
ethylene, amylene, all of the barbiturates, and others have
been produced, many of which have been abandoned because of
some defect or the other.
The induction of general an""sthesia hy the intravenous injection of drugs was first effected in man in 1872
by Ore; the drug employed was chloral, fifty-three cases
were reported, in fifty-one of which satisfactory results
were obtained.(7'7}

Further experience however, proved

that the procedure was not without dang;er and the method
does not seem to have been further developed until 1909.
In that year Burkhardt published his application of the
principle, using solutions of chloroform first, and then
later, solutions of ether.
In 1910, Professor Federoff, of St. Petersburg,
suggested the intravenous adminis+.ration of hedonal. (7'7)
Then, one by one, ether, hedonal, paraldehyde , and the
so numerous barbiturates sprung into prominence, each in
turn occupying the attention of those inflammed with the
idea of finding a perfect intravenous anesthetic.

The

r

7.

literature concerning the history of this search is far too
vast to consider at this time, and will be taken up under
each individual discussion of the separate drugs.

8.

INTRAVENOUS ROUTE IN GENERAL

Five to ten years ago, some men felt that most of the
old, time honored anesthetic agents were to be discarded,
and to be replaced bv certain widely proclaimed new anesthetics and that the long established inhalation route for
general anesthesia was to be but little used and that the
intravenous route would supplant the pulmonary way.

A re-

view of the literature on anesthesia, a consideration of
the reports of anesthetists and their evaluation of the
experiences with some of the recently introduced anesthetics and methods, compels one to feel that there is no ideal
anesthetic nor perfect method, that there is no possibility
at present of discarding either old anesthetics nor old
methods, and that each anesthetic and method, whether old
or new, has its definite indications as well as its equally
definite contra-indications.

According to M. Babcock, (81)

the wrangle over intravenous anesthesia versus inhalation
anesthesia is a most unnecessary thing, because there is a
definite time and place for both in +he field of anesthesia.
Felix Rood, (76) is one of the more pronounced champions of the intravenous cause, and states that excellent
though admi. nistration of anesthetics b•r inhalation are,
there are certain inherent defects in any method of administration through the respiratory tract.

Although in most

cases the results obtained by inhala+ion-are good, cases
very frequently do arise in which the objections to this

9.

method F.re of very great importance.

An attempt may, per-

ha ~, s, be made here to enumera t.e some of the more commonly
str-ted difficulties suggested by those opposed to the inh;-;lation route.

In the first place, one is limited to the

use of highly volatile

substan~es,

f'nd it is probable that

if solubility rather than volatility is the physical factor
required, the number of nvailable drugs may be
creased.

~reatly

in-

Rood, (76) contends thRt the respiratory method

must always in essence, be indirect.

The anesthetic is

absorbed from the vapor introduced into the air passages,
so th!-1t the dose actually entering the blood is rendered
vrriable by the variability \t.i th w11ich it enters the chest,
being subject to all of the accidents of laryna;eal spasm,
resniratory spasm, and of variations
of respiration.

~n

the depth and energy

Another argument common among the support-

ers of the lntr&.venous route is that the exposure of a very
l:

r~e

surface of the respiratory tract to an irritRting gas

must be regarded as a disadvantar:e and

dan~er.

This seems

quite logical, because most of us hf:ve at some time inhaled
a strong breath of ether, and found it quite irritating,
.snd it seems reasonable that s1Jch a vanor used in a long
anesthesia mir.:ht at times lef; d to serious comolicr tions.
In operations upon the mouth, jaws, or pharynx, the difficulties of the SlJrs:>:eon are much increa.sed by his having to share
the field of operation with the

fn~sthetist.

It is clear,

I believe, from t.he various articles, th&t if the direct
~dministration

of the anesthetic by the blood can be safely

-------- - - - - - - - - - - - - - -
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effected, it does dispose of all of these difficulties in
the use of inhalation drugs, and leaves the way very open
for the intravenous route.
It is sometimes a little difficult to see the relative uses and disadvantages of a new medical or surgical
method in their true perspective; and it seems that one
of the most important questions connected with the subject
is a careful consideration of the indications for the employment of the intravenous method of i.:;nesthesia.

Perhaps

it would be well to enumerate the collective advantages
promulgated by the advocates of the intravenous route. (1)
Absences of deleterious after-effects both gastric and
pulmonory.

(2)

Introduction of a quantity of saline fluid

by means of which shock may either be combatted or prevented.

{3)

Absence of pulmonary irritation.

( 4)

In certain

cases the separation of the spheres of activity of the surgeon and anesthetist.

Points two and four, to me are quite

plausible arguments, but the others are not as baldly convincing, and need more proof to back them up.
Infusion anesthesia is by far the more complicated of
the tv.ro methods, ('7'7) This says Page, accounts for its more
limited use.
Bernhard Friedlaender, (67) attacks the problem of the
deleterious effects of anesthetics from a little different
an~le.

He believes that there are two distinct injuries

done, namely, injury to the vital functions, and injury to
the psychic element. He states that the former naturally is

I

11.

I

more threatening to the life of the org&nism than the latter,
and therefore, all attention is directed by the physician
and anesthetist toward the objective injuries of the vital
functions, and very little thought is given to the matter
of the psychic element.

From the standpoint of vital funct-

ion, Friedlaender, {6?) says that he considers the inhalation anesthetic "ether" to be the least harmful, and the most
adantable anesthetic in that respect.

But, his contention

is that any inhalation anesthetic, presents definite possibilities of injurying the psychic element.
Friedlaender does not stand alone on this point, as
a review of the literature will show.

Many men register

that definite complaint against inhalation anesthesia without pre-medication or basal anesthesia.

The induction of

an inhalation anesthetic may produce a severe and often
lasting psychic trauma upon the patient.

In turn the psych-

ic trauma will cause shock and will undoubtedly reduce the
resistance of the organism. (67)

From personal experience,

one knows that the fear instilled in one immediately upon
placing the anesthetic mask over his face, is often greater
than the fear of the operation or procedure.
We speak of intravenous anesthesia as the direct method of anesthesia because by this method we do not require
the assistance of an intermediary system, such as the respiratory or the G.I. tract to assist us in our anestheti7.ation.

The anesthetizing agent is 9laced directly into the

bloodstream, through which medium it presumably acts upon

----------------------

r
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I

the C.N.S.

From the point of view of the anesthetic, then,

the method is direct.

Flagg, (79) has summed up the most

complete, and wholely impartial views on the subject of
intravenous anesthesia, and lists the advantages and disadvantages as follows:

1.

The general anesthetic nru.st be

preceded by an operation under local anesthesia,(meaning the
lnsertion of the cannula).

2.

The preliminaries to the

administration of the anesthetic involve a loss of nru.ch
time and, from this point of view, the method is impractical as a routine in the large hospital.

3.

The proper

administration implies familarity with the surp;ical technique required.

4.

The blood presPure is raised, the

bleeding is increased and the fluid ha_s a tendency to collect in the abdomen.

5.

·It is an open question as to the

harm done by the injection of a normal saline solution in
the bloodstream of a healthy patient.

6.

The possibility

of septic thrombosis must be considered, and the tendency
to pulmonary edema.

The fore-going were all disadvantages

and the following is a list of the compliation of advantages.
1.

Ideal control of the administ·ration.

2.

upon the rate or the depth of the respiration.
minimum amount of the anesthetic is employed.
little or no cumulative action.

5.

~~bove

3.
4.

The
There is

The technique is suff-

icently complicated to exclude thoughtless
The

Not dependent

expe~imentation.

a!'e only a few of +he pro and con c11mulati ve

tho'J,Q;hts concern:i.ng a very argumentative subject, and further
mol'.'e scrutlnizing consideration will be dealt with in the
following consideration of the drul2'.s admtnistered intravenously.

r-
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ETHER

The method of introducing ether intravenously was first
i.ntroduced by Burkhardt, and his immediate successes encourv~ed

others to follow. (83)

At the Berlin Surgical Congress,

Kummel was able to report ninety cases.

In no case of the

ninety did post-anesthetic vomiting occur,

althou~)l

in a

large number of the cases the operations were done for abdominal diseases of the gravest kind.

Burkhardt used an

ordinary infusing apparatus containing a 5
ether in normal sal:i.ne.

% solution

of

He allowed enough of the solution

to run in to produce anesthesia, then interrupted the stream
until the patient showed signs of coming round, when the dose
was repeated. (83)
It was soon realized that the interruption of the stream
brought with it a tendency to thrombosis in and about the
cannula.

To counteract this disadvantage two

ves~els

were

arr"'nged, either of which could be connected with the cannula
separately; one contained ether solution and the other held
normal saline.

In this case, the continuity of the stream

was maintained with the saline in the intervals between r.he
administration of ether.

The great objection to methods of

administration by periodic doses is that it is necessary to
produce a greater concentration of the anesthetic in the
blood after e8ch dose than is essential for adequate anesthesia. ( 83)
This principle was fully emphasized by those to whom is

-

- - -
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owed the introduction of the Vernon Harcourt a:ipar2tus.

The

chief modification introduced into this apryaratus by Felix
Rood, (83)

WPS

an indicator rendering possible a minute

graduBtion of the in-flowing s+ream.

The BppRratus consists

of an u-oner reservoir to contain e supply of the solution.
This reservoir is connected by a rubber tube to
chamber.

n

regulating

This chamber besides acting as a rer;ulator also

acts as an indi.cator.

And, although the stream of fluid is

interrupted so that its rate of flow can be seen, the nressure at the same time is not interrupted, but is transmitted
continuously to the top cushion of air contriined Pbove the fluid
in the regulating chamber.

The fluid then passes from the

recmlating chamber to the warm" ng chamber and so on to the
cannula.
Ether is

so~1ble

ner cent b:r volume.

in normal SPline to the extent of 10.8
It was found thrt with a. 101 solution of

ether, a tr>=nsient hemoglobinuria occurred. (83)
of this, Rood used a
globinuria followed.

5~

On account

solution, Pnd found that no hemo-

In order to be still more certain that

thel"e wr s no blood destruction, a number of snecimens of the
blood were tPken at. intervals throuv.hout several administrations.

These wer'e examtned microscopically, !'nd showed no

hemolysis.

These should be sufficient grounds to s·y that

the"'e is no blood destruction by this method of nnesthesia.
The usual preparation of the arm takes place, and a
little local

anes~hetic

the cannula tied in.

is injected and the vein exposed and

Strict asepsis must be used.

When the

15.

cannula is fixed into the vein the solution is at first allowed to flow in rapidly, the

regulatin~

tap being turned full on.

Induction of anesthesia is usually quite smooth and rapid, three
or four minutes being the average time. (83)
Rood, strugr:ling during induction is rare.

According to
The ordinary signs

of anesthesia, of course occur-- automatic respiration, muscular
relrxa+ion, and abolition of reflexes.

As soon as the smooth

anesthesia is established, a little experiment will enable one
to arrive at the minimum amount required, and the apparatus
can be set to deliver this amount. {71)

The noticeable

features of this anesthesia, according to Felix Rood {83),
who seems to have been an authority on this type of anesthesia, were the regularity and smoothness, and the ease with
which the anesthetic could be administered, and the great
rapidity with which the Df:;_tients responded to slight alterations in the dosage.
The striking

advant£Lg~s

of the method are seen in those

cases where the patient is in a condition of extreme inanition.

These patients often leave the table in a much better

sti;te than they were in before.

So that in any case in whid::l

the pHtient is likely to be benefited by a saline infusion
either as a means of relieving shock or hemorrhage, or if
shock is expected, this method has given excellent results.
The relaxHtion obtained by this method, states Rood (83)
of the ebdominal wall, is quite equal to that produced by
any other anesthetic, excepting stovaine, and for any type of
case in which ether as an anesthetic :is not contraJ.ndicH ted,
this method has the one great

advanta~e

of absence of un-

16.

nleasant aft.er-effects.
_..,
sur~ical

Some of the records of the German

clinics show that this is a marked feature of in-

fusion anesthesia.

Kummel reported ninety cases, and in no

case did post-anesthetic vomiting occur.

Rood (83) was not

quite as fortunate in his cases, but out of 136 cases only

A vomited at all, and of these, three were cases in which
blood had been swallowed during; the operation.
Of course, in reading any of the literature on this
subject, one must remember that when this method was used
it was far before anyone had even dreamed of the discovery
of the efficacy of the barbiturates intravenously, and so
it did seem quite marvelous to them ths.t they he.d found a
new route and method of administering anesthesia without the
old bug-bear of post-anesthetic nausea and vomiting •.
As a general criticism of the method, it was
by many that it was too complicated a procedure.

sug~ested

Rood (83)

admits this, but st.ates that any great simplification of the
technique or apparatus might lead to tlie adoption of an impromptu method with possible disasterous results.

It must

indeed, have been a huge and clumsy piece of apparatus, but
from the records it must have also been a fairly efficent
mode of administration.
Schlesinger, ('71) in his discussion of this mode of
ad.mini st.ration, stated that intra venou. s methods of giving
ether hF.d a very definite but limited application.

At this

time the battle w&s waging over the superiority of ether
over hedonal when given b;r infusion, and he claims that the
advantaqes of ether over hedonal were that the patient came

1'7.

round more rapidly; that ether was excreted by the lungs Hnd
caused much less bleeding, and that no vomiting occurred with
this method.

He also stated that thrombosis, if it occurred,

was due to faulty technique.
One of the questions that immediately comes to the reader's
mind, is how much was the total amount of ether introduced by
this method in attain:i.ng anesthesia?

Schlesinger ( '71} makes

the following statement concerning this point.

"The ether

solution is allowed to flow rapidly until the patient is anesthetized, which requires about 10 m-tnutes of time, and 8
ounces of the solution.

After anesthesia is established the

rEte of administration is much slower, about 16 ounces of the
solution per hour being ordinarily sufficent."

Felix Rood,

('76) reports one case of 3~ hours adm:tnistration, in which.
4~ ounces of ether and 4~ pints of saline solution were used,

and several cases of over two hours duration.

Flagg, ('79},

states that the amount of the solution adm"nistered depends
upon the duration of the anesthesia, and that this amount
varies from 500.-3500. c.c., with 1000. c.c. per hour being
the averaP-;e.
H. Kuttner, (74) one of the first to use the method
in suri;;ery, cautioned ap.;ainst the dan2'.er of air embolus End
thrombosis, but these dano:ers were greatly diminished by the
con+inuou.s flow system.

Goyane' s advocacy, (74} of the plan

of introducing the ether and saline i.nto an artery was not
well responded to; indeed, the

advant&~es

celaimed for the

method hardly counter-balanced its obvious dangers.

Th:is

18.

much had been demonstrated in the very e1;.rly days of ether
anesthesia, "b7 Flourens and Claude Bernard.

Professor

August Bier, Dr. J.L. Ransohoff, and others sought to avoid
these perils by localized intravascular injections of various
drugs cut off from the general circulation bY ti!thtly fitting
bands, but this procedure was of limited application. (74)
At this time, intraveno·,1s infusion was confined to the use
of ether, hedonal, and less frequently wlth that of paraldehyde. (72)

At this time also, Chloroform was employed in

this way, but it was found to be so highly dangerous, that
it was soon cast aside
Fnesthetics.

b~~

those in search of new intravenous

The infusion anparatus used for all of these

drugs was the same, and the apparatus was such a unique and
complicated mechanism, that I think that it would be of
interest to take it up here, in a more detniled manner.
As stated before, F.S. Rood (76) elaborated the apparatus.
It consisted of a glass reservoir capable of holding about 3
pints of saline containing ether, this reservoir was controlled bY a stopcock and connected by a rubber tube with a regulRting chamber.

This chamber had three openings, one

uniting it with the reservoir, one connecting it by a rubber
tube with the warming chamber controlled by the stopcock,
and one that e>.dmi tted. Hir, and yet was capable of air tiJ?,ht
occlusion by means of a rubber stopper.
tap was opened

~nd

the

regulatin~

When the reservoir

chamber tap was closed, the

saline ether solution entered the regulating chamber and as

19.

soon as this was half full, the air inlet was closed by inserting the stopper.

As a result the air in the chamber became

compressed by the fluid in the chamber, so th t the fluid, as
0

it escaped from the regulating chamber into the warmtng
chamber was under pressure, and so passed in a continuous flow
into the tube connected with the cannula.

The warming chamber

was immersed in warm water, the ob,iect being to warm the saline to a temperature below that. at whlch ether escapes in
bubbles.

This chamber had its egress tube nearly half-way

below its summtt so that any air or volatilized ether would
rise to the top of the chamber while only fluid went through
the egress tube.
In administering ether thusly, full flow was permitted
at first and in a mtnute or so the patient's breath would
smell of ether, and anesthesia would rapidly follow.

The

ether supply was then lessened, but cessation of flow was not
allowed because of

dan~er

of clotting in the cannula and sub-

sequent danger of emboltsm.

It need hardly be pointed out

that the utmost vigilance was necessary in watching the signs
of anesthesia, lest the flow be too great and ultimate death
occur.

Koenig, (74) and others asserted that

fat~l

accidents

often resulted from excessive quantities of saline-ether
entering the cir011lation by over-sight.

It has been shown

that saline solution rapidly leaves the blood vessels, and
Professor Bayliss, (74) proved that the addition of gum
P-cacia p,..evented this, so bringing un the change by many,
and substitution of the Bayliss gum saline as the vehicle

----
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for ether.
This method while now frowned on, and laughed at, at one
time was thought to have the ultimate of desirable qualities
and may have had as enthusiastic following as some of our
present day drugs have.

Many thought that the possibilities

of this new anesthesia would be unlimited.

By this method

anesthesia was induced without struggling or discomfort, it
wns light in character, and the patient resumed consciousness
within a few moments after

cuttin~

off the ether solution,

i:ind so little wonder that it was thought to be a new hnd
wonderful discovery and a boon to future anesthesia.
Buxton, in his book "Anesthetics 11

,

('74) states, "the

type of patient that suggests saline infusion to stave off
shock is peculiarly appropriate for intravenous etherization.
Abdominal sections, especially in acute cases, are quite
suitable.

The young and the

a~ed

lend themselves equally to

it if due care is tHken to limit the amount infused to the
capacity of the patient".

He evidently was a firm believer

in the efficacy of intravenous ether, but to me, the joker in
the above quotation lies in the last 16 words, for that is
exactly where intravenous ether fell down, and most of the
products that supplanted or succeeded it, as someone's idea
of the ultimate of desirable qualities in producing anesthesia, also lost face and failed in that respect of
its determination in individual cases.

dosa~e

and

There are many men who

even staunchly hold to the principle that one of the basic
requirements of an anesthetic is that it does not conform to
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the title, "a fixed dose drug", and c-i.s will be shown later,
their reasons for

F·

dherence to this principle are quite

sound.
Flagg, (79) sums up the question of intravenous etherization with the following points in reference to the
relative advantages and disadvantages of its use.
advantages are as f'ollows:
ministration; 2.

1.

The

Ideal control of the ad-

It is not dependent upon the rate or

the denth of the respiration; 3.
the anesthetic is employed; 4.
cumulRtive action; 5.

The minimum amount of
There is little or no

The technique is sufficently com-

plicbted to exclude thoughtless experimentation.
disadvantages of the method are:

1.

The

The general anesth-

etic must be preceded by an operation under local anesthesia; 2.

The preliminaries to the administration of the

anesthetic involve a loss of much time and, from this
point of view, the method is impractical as a ront1ne in
the large hospital; 3.

The proper administration implies

familarity with the surgical technique required; 4.
blood pressure is raised, the bleeding is

incre~sed

The
and

the fluid has a tendency to collect in the abdomen; 5.
It is an open question as to the harm done b'r the injection
of a normal saline solution in the bloodstream of a normal
. healthy patient; 6.

The possibility of sentic thrombosis

must be considered; 7.

This author believes thet there is

a tendency towards pulmonary edema.
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HEDON AL

In the extensive search for new derivatives of the
known

dru~s,

the discovery of Hedonal was made.

Hedonal

was made from the secondary methyl-propyl-carbinol bv
he.sting it with urea nitrate under pressure.

Thus, it

was a derivative of urethane, and possessed the chemical
formula C6Hl302N.

It was used quite extensively for the

production of anesthesia by intravenous infusion, but
unlike its cousin, urethane, it was soon discarded, nnd
fell into disfavor a few years after its discovery. (70)
Hedonal is a white crystr.lline solid, stable at the
ordinary temneratures.
,i

.

Its solubility in water at 100.

degrees F. is 1 in 100., and it readily crystallizes out
of a saturate&

solution in long, fine needles.

This

solution ce.n be boiled without the prope·,,.ties of the drug
being affected.

However, prolon·!ed heating diminishes

the concentration owing to the volatilization of a certain
amount of the compound.
In 1910, Professor Federoff, of St. Petersburg, suggested the intravenous administration of hedonal. (77)

However,

since 1900 this drug had had some voo;ue as a hypnotic; it
had also been given by mouth (in several Russian clinics)
as a precursor of chloroform and ether with sattsfactory
results.

Reports of its use as a general anesthetic first

appeared in Russian journals, a preliminB.ry note was nublished in German in 1910, and in the following year the
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technique employed, was described by Jeremitsch, with the
details of sixty-five cases. (77)

Later, at the Congress

of the German Surgical Association, Federoff contributed
a brief account of 530 cases collected from three Russian
clinics.

The high-light of the report

no death directly attributable to the

WES

th.B t there was

anes~hetic

in the

series.
Experiments on animals by Dreser ('77), showed that
hedonR-1 had 10 tlmes the hypnotic effect of urethane and
twice that of chloral; he found that the respiration was
no materially affected in conditions of deep narcosis,
although it did cause a sliltilt fall in the blood

pressu~e.

Dreser noted that the drug had a diuretic act5on, wh1ch
was attributed to the theory thht in the body the substance
was broken down into urea, carbon dioxide, and water.
Lamusakow ('77) carried ont further experiments, and found
that in

do~s

and rabbits, a dose of 0.4 to 0.5 grams to

the kilo of body weight produced

~eneral

anesthesia, and

that the respiratory and cardiac rhythm remained regular
under this dose.

When he gave toxic doses, the heart

continued beating, r.fter paralysis of the vasomotor center.
He considered that the presence of the ami.no radical antagonized the paralytic action of the drug.
Federoff and Jeremitsch, after havtng satified themselves by experiment on anim1:,1s, adopted the use of hedonal as an anesthetic for man.

They employed an interrupted

infusion method, a 0.'75~ solution in normal saline was
injected under air pressure.

The needle was inserted into
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a superficial vein, and sufficent of the hedonal solution
wt:s injected to produce anesthesia; the needle was then
withdrawn and reinserted if a prolonged anesthesia was
necesRary.

The results obtained were, on the whole,

satisfactory, but less so when leg veins were injected.
C.M.

Pa~e,

(77) whose apparatus for intravenous infusion

was later modified by

z.

Mennell, used this means of ob-

taining anesthesia in a number of cases, and regsrded it
as a valuable method.

However, he did caution against its

employment in what he chooses to call "unsuitable cases".
Page found that the average amount of hedonal solution
required to produce anesthesia was 500. c.c., and that the
induction period ranged from 2. to 13. minutes.

He found

that the narcotic effect of the hedonal nersisted for a
lon~

time after the infusion had ceased, and remarked that

this was a Ve!"J undesirable feature of the method.

Another

undesirable feature was the fall in blood pressure and +he
appearance in a great many cases of cyanosis 1
out as a possible

dan~er

Pa~e

noints

the onset of cyanosis, and Federoff

recorded some instances of temporary cessation of respiration. {77)
Hedonal, as supplied by Bayer, is dissolved in normal
saline at a temperature of

ryo.

degrees F., to make a

0.75~

solution; the resultant fluid is filtered once, boiled for
five minutes, and stored in sterile flasks.

The contents

of the flask are warmed up to about 140. degrees F., and
poured in a tank, which is furnished wtth a thermometer
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gauge and tapped exit tube.

From the latter runs a yard

of pressure tubing; in the course of this a dropper is
inserted; it terminates in an ordinary fine infusion
cannula.

Before infusing, the temperature of the fluid

in the tank is reduced to about 115. degrees F.

The

usual exposure of vein is done, and the cannula tied in.
The fluid is run in at a rate of 50. to 150. c.c. per
minute.

The rapidity of flow can be accurately controll-

ed by regulating the tap of the tank and watching the
flow

throu~h

the dropper.

Within a minute or so of the commencement of the
infusion, the natient becomes drowsy, and often ya¥ms; he
hfls a subjective feeling of WHrmth and well-being, the face
flushes, and if the infusion is too rapid a certain degree
of cyanosis arises. (77)

Then follows a period in which

the patient appears to be in a state of deep natural sleep,
and this state quickly merges into one of deep anesthesia.
The amount of fluid necessary to induce anesthesia
varied considerably-- e.g., 40. c.c. sufficed in a child
aged 10 months; 1,000. c.c. were necessary in a heavily
built man, aged 25; the average dose necessary in an
adult was found to be 500.· c.c.

As stated before, the

period of induction varied from 2. to 13. minutes.
The rr:te of return of complete consciousness is slow
&nd varinble, and to most of the experimenters this was
recognized as a serious draw-back to the use of the drug.
Usually the patient slept for six to twelve hours after the
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cessation of the anesthetic and then awakens.
often persisted for twenty-four
I notj_ced cases where numerous

hour~.
~imes

In some

Drowsiness
art~cles,

emotional disturb-

Fnces occurrf:d, E..:ncl ;;, 1Jeriod of excitement came on an hour
or so after the operation.
undesirable feature.

This too, is certainly a auite

On further reading, I found numerous

cases where vomiting and headache·were common occurences.
Some of the dangers of hedonal anesthesia are cyanosis,
postoperc..tive excitement, and resnira+-ory failnre from overdosage.

Federoff, (77) reported that temporary stopnage

of respiration occurred in eight of 530. cases, but that
after the use of artificial respiration, normal
started again.

b~eathing

Some of the other undesirable features

noticed were the prolongation of narcosis after the operation, esnecially with reference to the possibilities of
inhala~ion

of vomitus.

The sponsors and champions of hedonal administration
claim the following advantages in it,s use.

The technique

is simple, the solution is re<o.dily handled and sterilized, and the active part is not volatile.
question as to the relative advantage or
volatility of the drug offers.

Here arises the
disadvanta~e

the

To me it seems as though

volatile drugs should be safer, because of t.he mor>e. prompt
and effieent elimination attained by way of the lungs.

As

one can see by looking over the advantages listed above,
e.ny and all of them, are certainly open for argument, and
far from convincing.

The rest of t.he advantages given by

2'7.

those

championin~

t.his drug, I will merely state, without

comment, and the reader can take them for what they are
worth in his consideration.

Page, ('7'7) concludes with the

stBtement that, "the anesthesia attained is of [-; stead;r and
complete type, the relaxation of the muscles is remarkable
being often as good as that p;iven by sninal [,nesthesia.
The respiratory movements are steady rnd quiet.
moval of the

~nesthetist

The re-

from the scene of the operation

in herd and neck cases is a distinct

advanta~e.

The quiet

sleep, insensitiveness to pain, and nbsence of straining
1-1re other <dv;ntages."

There are other statements, too

numerous to list, but one of them that I found listed as
an edvantage, seems to back-fire and act as conclusive
evldence as to the drug's undesirability.
is

BS

The statement

follows, "owinp: to the comnaratively slow rrte at

which the drug is excreted, ve

-,y

small quantities of the

solution suffice to maintain anesthesia when once it is
completely established." ('7'7)

The fact that it :i.s slow-

ly excreted seems to me a distinct disadvantage, because
I believe, at the present +ime, the general consensus of
opinion is that the faster the rate of elimination, the less
toxic the drug becomes, and the. more desirable it is as
an enesthetic.
It was found that hedonal infusion was unsuitable
for cases in which nulmonary engorgement or a gross
cardiac lesion existed, for operations unon the airnassap;es, fand for patients with high blood pressure.
The experiences of the

~re&ter

share of those working
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with this type of anesthesia, confirmed Burkhardt's views
of the danger of :tntravenous hedonal. ('75)
~reat

Not only have

complications arisen from its administration, but

deaths have resulted from its use. ('74)

A discussion on

the use of hedonal, held before the Medical Society of
London, provoked somewhat diverse views, but the consensus
of opinion was ar,ainst the use of intravenous hedonal. ('78)
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SOMNIFAINE

The men who have done considerabl·e work in the field
of anesthesia with this drug, and those who have been its
chi.ef advocates, are, in the vast majority, workers on the
European continent.

Comparatively little literature on

this subject has been written by clinicians of England
or the United States, and the tise of this drug has never
been accepted, in these countries, with much enthusiasm.
This drug is really a combination of two hypnotics which
are derivatives of the malonyl-urea group.

The two sub-

stances are diethyl-barbituric acid and allyl-isopropylb&rbituric acid.

This combination received considerable

attention in Europe since 1921, but seems not to have
interested the profession in this country to any great
extent.
Its origin, in 1920, is

cre~ited

to Redonnet, and

Cerne was the first to use it in relieving the pains of
labor. (19}

During 1921-1923, Bardet and v. Cleisz

developed its clinical use in obstetrics, and Fredet
and Perlis used it in minor surgery, later extending its
use to major surgery.

Since then, there have been in the

foreign literature quite a number of articles by
authors.

v~rious

The results reported have been variable.

In

1925, H.M.F. Behneman after seeing an article on its use
interested O.H. Schwarz of Washington University in the
drug.

Before trying it clinically however, Schwarz
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wanted to have some experimental data available, and
Behneman and Woodmansee undertook an investigation of
the substance at 1Nashington University, St. Louis,
under the direction of the Denartment of Pharmacology.
Their results were not nublished and clinical use of
the drug was not attempted.

However, I. Macdonald, (60)

states that in 1926, in France, the experimental and
clinical researches of Fredet and his associates on the
use of somnifaine, or somnifene, as the drug was known
in France, seemed to show tha-e in intravenous in.i ection
for surgical anesthesia, the general anesthesia was
reduced to an extreme minimum, a.nd in some cases it was
eliminated entirely.

Hewer, (58) in his general discuss-

ion of anesthetics, states that since the Great War, the
i.ntravenous injection of somnifaine has been practiced
in France, to a certain extent, but the excitement seen
was regarded as too detrimental for its common use.
The drug, as said above, :ls a combj.nation of diethylbarbiturate and allyl-isopropyl-barbiturate, in 2. c.c.
Ampoules, containing 0.10 gram of each drug in the form
of a diethylamine salt.

The solution is rendered stable

by the addition of small amounts of alcohol and glycerine.
Recently, a new form has come into use in ampoule form,
in which the allyl-isopropyl-barbiturate is the only
constituent.

This form was advocated bv Fredet, (19)

and I. Macdonald. (60)

According to the foremost worker

on this drug in the United States, J.H. Fjelde (19)
•1:

'

-----~----------------------.
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.

the reason for the preference of this new drug, over
the use of the old combination, is that the diethylbarbi turate in the old drug, was eliminated rather slowly, and had, therefore, a delayed end prolonged effect
which, in the opinion of most, was undesirable.
Allyl-isopropyl-barbiturate has the highest lipoid
solubility of all the barbiturates so far kno\im, a feature which according to the most up to date conceptions,
( 19) is of prime importance as regards the hypnotic acti.on.

Due to this high degree of lipoid solubility, it acts
very quickly, so that sleep arises within a few minutes.
According to the literature, allyl-isopropyl-barbiturate,
is about five times as hypnotic as, for instance, diet-hylbarbiturate, while its toxicity is not increased in the
same ratio as its hypnot-ic influence.

According to J .H.

Fjelde, (19) on the other hand, this hypnotic influence
does not last longer than desirable in the ordinary cases,
because the elimination of the drug, from the system proceeds rapidly.

This drug should, therefore, leave the

patient free from prolonged after-effects, a feature
which is of great importance in general medicine, and also,
owing to the rapid elimination even of large doses, the
chances of cumulative effects should be likewise p;reatly
reduced, when the drug is used over long periods of time.
Later on, 1_n

th~

clinical consideration of the drug, we

will see if this holds true for this drng.
Macdonald, (60) states that the interesting research
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done by Fredet,

demons~rates

that the seat of action of

Somnifaine is chiefly in the nerve centers, while J.H.
Pjelde, (19) is even more specific, and claims that the
action seems to be exerted directly on the sleep center.
The drug is car.,-·ied by the red cells, for which it shows
a special affinity.

It is fixed with predominence in

the nerve centers, but is retained to only a very slig,ht
degree by the liver, kidney, and other tissues.

When

introduced into the blood, it is eliminated unchanged by
the kidneys, Hnd elimination commences very soon after
injection. (19}
Somnifaine, in non-toxic doses, but of sufficient
strength to produce anesthesia, exert only a slight effect
on the respiratory and cardiac centers, and the blood
pressure also shows very little alteration.

F.ielde

says that there is a slight lowering of the pressure
after injection, but that this quickly recovers.
liver function likewise is not altered.

The

That the glyco-

regulatory mechanism is not affected, w&s demonstrated
by spontaneous p:lycosuria after injedtion of sugar.

Fjelde's interest in the intravenous form of obstetrical an?sthesia led him to obtain the drug, and in
October, 1926, with Kent E. Darrow, he started to use it
in various surgical conditions.

He also used it in about

100. obstetrical cases, and states that the results were
r:enerally good.

In surgery, he usually combined it with

local or caudal anesthesia, or ethylene, the latter
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combination was the most frequently used.
In using somnifaine in surgery, there are two dist:i.nctly different pha.ses of its use:

first, the preoperative

preparation for ethylene anesthesia; and, secondly, actual
anesthesia for abdominal operations, or in combination
with a local anesthetic.

To Fjelde, (19) the first one

is the more important method, because by its use, he has
practically eliminated the use of ether, and does every
type of

~bdominal

operation with ethylene alone.

claims this to be a distinct

advanta~e

He

because of the

occasional difficulty in obtaining good relaxation with
ethylene alone.

He states also, that the use of this

combination of somnifaine and ethylene cuts down the
ethylene necessary to one to two

gallon~

per minute, instead

of the usual two to three, and the nercentage flow is cut
to one half the maximum, supposedly, when fifteen to
ei~hteen

per cent oxygen is used.

The technique of Fredet 1 s method, as stated by I.
Macdonald, (60) is as follows:

1.

A hypodermic injection

of morphine is given, verying from a minimum of 1. cg. up
to 2. cg. as a maximum.

It is

advanta~eous

to associate

scopalamine with the morphine in doses varying from twothirds mg. up ·to three-quarters of a mg., according to the
weight of the patient, and whether his general st&te is
cachectic or satisfactory.

2.

From 20 minutes to 40

minutes later, after the morphine-scapolamine injection,
the intravenous injection of allyl-isopropyl-malonyl urea
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is made very slowly; 3 mjnutes, at le&st, should be
snent in the injection.

The dose is calculated Hccord-

ing to weight, age, and the general state of the patient.
Generally, in fairly robust adults, 1. cg. per kilogram
of body weight is used, never passing 0.07 gram; In the
aged or cachetic patients, 0.04 or 0.03 gram should be
enough.

Ampoules of the drug were obtainable containing

0.01 gm. in each cubic centimeter of water.

3.

Five

minutes after the in+-r&venous injection a small amount
of chloroform or ether was given to

pe~m1t

the incision

being made about 10 minutes after the intravenous injection.

During the operation the !'.!eneral anesthetic could

often be dispensed with, to be resumed should the patient
move and at the end, to facilitate the suturing of the
wound.
According to Macdonald, (60) postoperative vomiting
was very rare, and the patient awoke four to five hours
after operation to fall asleep quietly

a~ain.

He does

admit that excitement was frequently observed, and this
seems to be also the point that most clinicians found to
be unfavorable to its use.

Macdonald used this anesthesia

in 33 cases during a period of 2 years, and, although it
did not replace routine methods, it was his choice in 2
types of cases,--when the patient was a bad risk from
pulmonary complic:tions or from probable hepatic and
renal insufficency, and again when he was certain that
the operation must be prolonged.
In the Cardiff City Mental Hosnital about 50 cases
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were treated with Somnifaine during a two year interval.
The results, according to Quastel, (103) were definiteiy
encoura~ing

except in so far as toxic symptoms, including

the production of ketosis, were demonstrated in a large
percentage of the cases.
so slarming thrt it became
treatment.

The toxic by-effects were often
neces~ary

to discontinue the

It was felt, however, that the success obtain-

ed in the prolonged narcosis treatment of many cases of
mental disorder warranted a search either for new drugs,
which would produce sufficently deep narcosis without the
demonstration of toxic by-effects or for a modification
of the then present methods of obtaining narcosis, which
would diminish or eliminate the toxic action.
The toxic effects of narcotic treatment with the use
of somnifaine, have been described bY A.M. Meerloo, and
M. Muller (103).
deran~ements

These include bulbar symptoms, such as

of swallowing mechanism, indistinct speech,

ataxia, tremor of the lips, and vasomotor paralysis.

A

frequent accompaniment of prolonged narcosis is the development of ketonuria, which becomes more marked as the
narcosis proceeds.

Doubtless, the effect has much to do

with the actual dosa.r;e of the nHrcotic, certain patients
responding more

vi~orously

than others.

In the past, it

has always been considered advisable, according to
Quastel, (103) to cut short treatment with somnifaine as
soon as a definite ketosis has been produced, and considering the drug as a whole, he sta+es that he believes
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it is very rdvisable to entirely dismiss it from clinical use, until some change has been made whereby the
present dangerous ·toxicity has been decreased to a very
considerable degree, or better yet, eliminated entirely.

------------------~-------------------.
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p P.RALDEHYDE

From the formation of the word, we would expect to
find that aldehyde had been ns.med bv the Arabian alchemists.

On the contrary, the

dru~

is of comparatively new

discovery and was named by Liebig, (110) who contracted
the name alcohol-de-hydroi:r,enatum, to aldehvde.

Aldehyde

is prepared from alcohol by the action of manganese dioxide 'nd sulphuric acid gently heated toaether.

Paral-

dehyde is formed by polymerization or linking together of
three moiecules of aldehyde and is rrepared by adding a
small proportion of pure sulphuric acid to acetaldehyde.
Paraldehyde is a clear, volatile, inflammable liquid
h1·. ving an unpleasant penetrating odor and a disagreeable
taste.

It is soluble in cold water to a

than in hot water.
m1neral oil.

~reater

degree,

It mixes freely with vegetable or

It freezes at a comparatively high temper-

ature with formation of a white solid.

Accordtng to

Cushny, ('72) paraldehyde is a polymer of ethyl-aldehyde,
resembles alcohol in its effects, though it is a much
more powerful narcotic, and rarely induces any symptoms
of excitement.

It does not effect the heart directly,

even in large doses, and has no such effects on the protein
metabolism as hf, s been observed under the prolonged use
of chloral.

The pulse is slightly slower and the carbonic

acid exhaled is less than normal.

These changes, however,

are due to the muscular movements being lessened and are
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hardly greater in extent than the changes that occur in·
nr: tural sleep. ( '72)

According to Noel, ( '72) very large

quantities have been t[;ken without fatal results and in
fact without any more serious consequences than prolonged unconsciousness.
Paraldehyde h•- s been extensively used as a hypnotic
and sedative, especially in the treatment of acute alcoholics and for controlling the violently insane.

It is

commonly stated to be the safest hynnotic known. (110)
f
'.

t

It acts first on t-he cerebral centers and later on the
lower parts of the nervous system.

It has no deleterious

effects on the circulation, respiration,. blood pressure,
or metabolism.

It is excreted unchanged,

lar~ely

the lungs but partly bv the skin and kidneys.
effect is a mild diuresis.

through

The renal

There are no known subsidiary

effects on the functions of other organs.
Dr. George A. Elliott, (110) formerly of Butler
Hospital, now at the Connecticut State Hospital at Middletown, has made an intensive study of blood chemistry
.following the intravenous injection of pllrEtldehyde.

He

injects from six to nine c.c. of pure paraldehyde as an
anesthetic for minor operations.
a powerful antiseptic

~;_nd

anesthesia appeared almost

ne2d

Paraldehyde is itself

not be sterilized.

im~ediately

'l'he

and lasted for

several minutes, long enough for dental extractions and
various minor operations.

There was complete relaxation,

some fall in blood pressure and some resniratory depress-

--------------------------------
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ion.

The blood was tG-ken for chemical examination a hHlf

minute after the injection and at intervals during the
next twenty-four hours.

Blood sup;ar was undisturbed,

Non-nrotein nitrogen was unaffected.
1_mchanged.

Creatinine was also

The coagul< tion time was reduced from an

average of three minutes to ninety seconds.

'l'here

WbS

no bleeding after dental extractions, a pulmonfry hemorrhage frequently could be checked, and hemorrhap.;e from
a wound of the hand ceased after oral administration of
pnraldehyde.
The hypnotics vary in efficiency and in safety. They
vary in effect on conscious perception, on reflex <tcti vi ty,
and in their relief of pain.
produce sleep.

Pure hypnotics, as barbital,

Sedatives, as ·nr;raldehyde, in addition to

their hypnotic action, have a powerful an effect on relief
of pain that t' eir analgesic action overshadows their
1

hypnotic effect.

The immediate result of the administrat-

1.on of a narcotic is often stimulation rather than sedation of reflex activity.

In some subjects, therapeutic

dosage of narcotic relieves pain but has no hypnotic nor
sedative action.

On the other hand, administration of a

pure hypnotic in the presence of severe pain wi11 usually
not result in hypnosis, but in a state of active delirium.
These considerations indicate that narcotics are not ideal
pre-anesthetic h'rpnotics and that the pure hypnotics are
not suitable for relief of postoperative nain and discomfort.

-----------------------------~
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Noel, (72) h&s the following method of administrating
paraldehyde intravenously.
doses, 4. c.c. of the pure

Starting at fi "st with small
1

dru~

were injected into a vein.

Almost before the syringe was empty the patient was unconscious.

He slept naturall;"r for about two hours.

Sub-

sequently 8. c.c. were injected with sat:tsfactory results.
It was found, however, that the pure drup; caused a certain
amount of locrl discomfort and coughing, and it was therefore diluted with saline to form a lO;'t solution.

One

hundred c.c. of this solution produced in about 40 seconds
an anesthesia lasting about twenty minutes, and suitable
for mi_nor suro:ical procedures.

Paraldehyde, while acting

temporarily as an anesthetic, had a prolonged hypnotic
effect, considerably reducing the amount of ether subsequently required.

Being volatile, it was rapidly ex-

creted by the lunas, and this, says Noel, (72) is an
imoortant element jn the safety of the drug, and an advantage which could never be claimed for the use of hedonal.
In comparison with avertin, paraldehyde has less
effect on conscious perception and memory, less effect in
relief of pain but a greater depression of reflex activity.
(110)

The pc.raldehyde patient may come to the oper1tion

apparently conscious and responsive to painful stimuli but
will develop

muscul~r

relaxation in the presence of severe

oper£:tive stimulation under a very small dose.ge of the
aneethetic.

Paraldeh'!de does not depress the respiration,

does not affect the blood pressure or metabolism.

It is

----

--------

---~~---------------
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~enerally

conceded that it is without effsct on the liver

and kidneys, and does not influence blood chemistry.
has a marked hemostntic effect.

It

In comparison with e.vertin

the margin of safety is very great, and the expense is
almost negligible. (110)
In comparison with morphine, paraldehyde is a powerful sedative but is inefficent in analgesic action.

It

does not depress the respiratory center and does not
stiIIn.llate the vomiting center.
urotective

cou~ning

It does not abolish the

reflex, and it does not check secret-

ions nor diminish the flow of ur:t.ne, on the contrary, it
is a mild diuretic.

In comoarison wlth morphine, paral-

dehyde has a very great margin of safety.
Paraldehyde is an efficent pre-anesthetic hypnotic,
showing a minimum of deleterious effects upon the organs
of the body and their functions.

Its margin of safety is

several times as great as that of morphine or avertin,
but less than tho:...t of the barbiturates, and for thct
reason, with the introduction of the barbiturates, it .was
soon dropped from clincal use, in favor of the more beneficial advontages f011nd in the use of the barbiturates.
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BA..'RBITUR1~TES

IN GENERAL

For years the medical profession has looked forward
to the nossibility of ::, drug that would numb the sensorium and make the patient oblivious to his surroundings
and yet not act in a deleterious way on any of rhe vital
organs.

Thierfelder Hnd von Mehring, (99) in 1880 made

the observation, which was later confirmed by others, that
the sleep producing action of alcohol was related to the
number of ethyl groups present.

A few years later,

Schmiedeberg conceived the idea of producing a nitrogen
containing hypnotic, knowing that intravenous injections
of ammonia preparations raised the blood pressure.

Then

Schmiedeberg succeeded in preparing urethane; and, following in the order named, pE,_raldehyde, amylene hydrate,
sulphonal, trional and chloroformamide were produced.
It was then observed that the intensity of the hypnotic action of sulphonal depended upon the number of
ethyl rsdicals linked to a centrHl carbon atom, and for

i

J
-I

this reason Fisher and von Mehring, (99) in 1903 successfully completed the synthesis of a nitrogen-containing
compound.

This substance was prepared by treating di-

ethylmalonic acid ester with urea and sodium ethylate.
The preparation was placed on the market under the name
of "veronal", the generic name of which is "barbitaln.
Since thr..-i. t time a large number of barbital derivatives
have been prepared, differing one from the other largely

i
'
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in the substitution of one or both hydrogen atoms by
other radicals.

It is possible to develop a great

number of these substances.
In 1924, Fredet and Perlais, (99) two Frenchmen,
succeeded in inducing general anesthesia with the barbituric acid series.

They used a mixture of di-ethyl

allyl-barbiturate (trade name "somnifene").
administered intravenously.

This was

In 1927, Bumm, following

the lead of Fredet and Perlais, used a barbituric acid
derivative intravenously.

This compound he believed de-

composed more readily than somnifene.

He utilized sodium

sec-butyl bromopropenyl barbiturate, (trade name is
"pernokton").
pernokton

W!:iS

He believed that the elimination of the
more rapid in the body .•;nd would permit a

more rapid recovery from the anesthetic than would be
possible with the other nreparation.
In 1926, Page and Coryllos, (63) used sodium amytal,
sodium iso-amyl-ethyl-barbiturate, to nroduce general
anesthesia in animals.
All derivatives of barbituric acid have certain
characteristics in common which have long been recognized:
1.

They are primerily hypnotics; only occasionally will

amounts ordin·rily producing hypnosis produce analgesia or
Sufficiently lar~e amounts will induce anal-

anesthesia.

gesia and anesthesia in both animals and man.

However the

dosage of such amounts precludes their routine use in
man. (64)

2.

There may be a marked variation in the

l

I

j
'

effects observed with a given amount in the same or different patient.

This variability of action has made it

difficult to select the proper dosage.

3.

The amount

required to produce a given therapeutic effect bears
ap:oroximl,_tely the same relationship to the fatal dose in
each of these various compounds, in their climtcal application.

4.

All members of the barbituric acid series may

depress the respiratory and circulatory systems when
amounts large enough to produce deep hypnosis are administered.

5.

Comparatively large amounts of any of the

derivatives of barbituric acid may produce hallucinations,
and so forth, when the amount excreted or destroyed reaches
a certain level.
Zerfas, (64) points out that derivatives of barbituric
acid have many characteristics in common, but differ largely
tn toxicity, and rate and manner of elimination.

Lundy, (87)

has recently m&de an exhaustive review of the literature
on this subject.

The therapeutic

mar~in

of safety, based

on experimental animal work, has been determined for a
great many of these compounds.

In clinical medicine we are

interested to know the proportion of the fatal dose that

'

will be required to produce a given effect.

For all

,

practical purposes that relationship is about the same for
all the commonly employed derivatives of barbiturlc acid.
Diethyl-barbituric acid, (barbital) is frequently cited as
being the least toxic of these compounds, mainly because
the amount required to produce death in animals is relatively

--------------------------------------
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large.

Should one desire to produce a given effect short

of the frtal dose, the amount of barbital required would
bear about the same relation to the fatal dose as that of
a compound considered two or three times as toxic.

Should

subsequent sub-lethal amounts of barbituric acid be given
before the en+ire amount was eliminated each time, barbital would ultimately prove decidedly more toxic than those
compounds eliminated or destroyed at a faster rate.
Fitch, and his associates, (95) state that there seems to
be little advantage that can be claimed clinically for the
intravenous use of one barbiturate over another, except in
so :far as the advantage lies in differences in duration or
depression and in the total quantity of the drug that the
organism must destroy or eliminate.
According to Friedlaender, (67) most of the barbituric acid derivatives such as ve»onal, amytal, allonal,
ipral, luminal, noctal and pernocton have been tried out
experimentally and clinically and their action bas been
similar in the human being and in animals; namely, as
sed1:tives, analgesics, or hypnotics, depending upon the
amount administered.

The toxi·c reacttons of :tndi viduals

to the various barbituric acid derivatives are essentially the sr;.me, with the exception of pernocton and
noctal.
The use of the derivatives of barbituric acid as
an·esthetics ond hypnotics has been closely studied in
the last few years, especially in the United States, and
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the literature is now extensive. (66}
no fewer than 466 references.

Lundy, (85) quotes

As regards the use of the

barbiturates in human surgery, one may draw the following
conclusions: (95)

1.

The employment of a barbiturate as

the sole anesthetic is inadvisable.

2.

As basal hypnot-

ics the barbiturates are among the most valuable drugs
available.

3.

The suitability of a barbiturate as a

bcsal hypnotic depends largely upon toxicity, and shortness of action.

The i;;reater the toxicity the smaller is

the dose required, and the smaller the amount of the drug
to be detoxicated or eliminated.
The barbiturates cE.m he

aa.m-~nistered

ways, either by mouth or intravenously.

j_n one of two
The former route

has the advantage of simnlicity, but Hccurate dosage, which
is essential for successful anesthesia and which varies
with each individual patient, is difficult to obtain.

The

intravenous method is commonly employed, because it allows
the minimPl effective dose to be determined accurately. (69}
With this, a solution of the chosen drug is injected at a
predetermined raf-e, ceasing when consciousness is lost.
The duration of administration varies according to the
toxicity of the drug employed; it is shortest with Pernocton
and longest with Amytal. (69}

A warning, however, was

issued by the Council of Pharmacy and Chemistry of the
American Medical Association, regarding the intravenous
administration of barbiturates.

It is stated that these

comriounds require large amou.nt s of alkali for solution;

amytal, for example, requires a

de~ree

of alkalinity the

equivalent of a buffer solution with a pH of 9.5, and
therefore this drug, and for that metter any other barbiturate, will not remain in solution with the chemical
reaction of the blood. (69)

The comoound is orecipitated

and then there is a foreign body, in the colloidal state,
within

&

sensitive colloidal system,--narrely, the blood,

whose physic-chemical properties rnd physiologic.el
f1.mctions are unintentionally and undesirably affected.
R.C. Garry, (69) states that this action, which is not
peculiar to the barbiturates, is probably responsible for
certain reflex effects :'rising either from the disturbed
colloidal equilibrium of the blood or from marked alkalinitv of the injected solution, or both.

These intravenous

reflexes which may be invoked by irritation of the depressor nerve endings or of the vagus nerve terminations in
the viscera, and which result in sudden circulPtory end
respiratory disturbances, are unnecessary and undesirable;
they complicDte the ordinary hypnotic action of the barbiturates, and submit the uatient to additional risk.
In view of these facts the Council of Pharmacy and
Chemistry maintains that any advantages thet can be procured by giving Barbiturates can be urocured by giving
them by the mouth; and that, in the present st&te of knowledge, the intrr-_venous route should be reserved for only
emergencies and for those cases in v(r:ich oral administration is physically impossible.

The wisdom of this attitude

-

----------------------------

48.

is

~enerally

recognized, for, although it is not in harmony

with the favoreble opinions, based upon clinical investi~ation

rather than upon pharmacological experiment, origin-

ally entertained regarding the intravenous administration
of these compounds, it is in the best interests of 'he
pHtient. (69)
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AMYTAL

One of the most recent derivatives of veronal is
amytal (iso-amyl ethyl.barbituric acid).

This drug was

first described by Shonle and Moment (62) in 1923, and
wi

s promptly used by Page, (63) in pharmacological ex-

perimentation.

At first the difficulty of preparing the

soluble sodium salt of amytal delayed the use of this
drug as an anesthetic for human beings.

Very recently

however, the presence on the market of the sodium salt
of amyt['l in stable form has permitted its wide application as an anesthetic in man. (64)

A full description

of the clinical use of the barbituric acid

~roup

of drugs,

both in surgical and in non-surgical cases, may 1-·e found
in the Proceedings of the Staff Meetings of the Mayo
Clinic. ( 85)
Intravenous administration of a 10% solution causes
a very rto.pid onset of anesthesia, but the injf'ction must
be carried out very slowly, because of severe circulatory
disturbances.

In man, 20-25. mgm. ner kilogram of body

weight is sufficient for complete surgical anesthesia,
and 12.-20. mgm. per

kilo~ram

of body weight is adequate

to lower the dose of such volatile anesthetics as ether,
or nitrous oxide and oxygen, to
required. (85)

t

of the usual amount

Stormont, Lampe, and Barlow,. (86) working

on rats, showed that premedicatlon with amytal or other
barbiturates permitted the nroduction of full nnesthesia
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with a lower percentage of nitrous oxide and a higher
percentrge of oxygen than is usually necessary.
In man there is a post-anesthetic sleep, and drowsiness, governed by

dosa~e,

for 12.-72. hours.

siderably increases the necesPary

nursin~

Neither in animals nor in man are there
operative distress. (87)

This con-

attention.

si~ns

of post-

The statement b;r early workers

that carbohydrate metabolism is unaffected by amytal,
made this dru.P.' the anesthetic of choice during the wave
of experimental investigation into carbohydrate metabolism which followed on the discovery of insulin.

This

swee:oing claim for amytal as a true nphysiolorr,ical"
anesthetic has not stood the test of time.

Glucose in-

jected intravenously is not removed from the blood at the
usual rate, presumably due to inhibition of the storap:e of
glycogen in the liver. (88)

However this may be, there

seems to be a general consensus of opinion that amytal
anesthesia has a less disturbing effect on carbohydrate
metabolism than the majority of other anesthetics in
general

UEe.

This may be not without significance in

anesthesia in man if damage to the liver is feared.
As is to be expected, amvtal lowers the body temperature, certainly by enforced inactivity and possibly by
a direct depressor 'Ction on metabolism.

All barbituric

acid derivatives are respiratory sedatives.

Amytal, how-

ever, in anesthetic dosage, does not greatly diminish the
mlnute-volume of respiration, and the respiratory center

-
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remains sensitive to carbon dioxide. (89)

Amytal has a

definite toxic action on the heart, and this is more mHrked the more rapid the adminis+ration. (90)

For this

ree_son rapid intravenous exhibition of the drug is fraught
with di:mger.

The blood pressure falls rapidly, and one

hour or more may elapse before it regains its previous
level.

This fall in blood pressure is due both to dilat-

ation of the heart, with reduction in minute-output, and
also to vase-dilatation. (91)

Large doses administered

rapidly may cause heart block, ventricular fibrillation,
and death.

In clinical use, amytal lowers the systolic

and diastolic pressure, and this fall in blood pressure
may be alarming if the administration be rapid. (85)
Because of the great controve!'sv over the use of amytal
in Obstetrics, the following information may throw some
licri1t on the sub,ject:

in vitro, amyte.l, even in h5_gh

concentration, has no effect on the movements of the
guinea pig uterus, 1::1nd the response to "pitocin", is
unaffected. (92)

Amytal has found great favor and has

been used successfully ln many obstetrical clinics.
Barbituric a6id derivatives do not all react in the
same way; they are excreted in variable amounts and with
variable speed.

Amytal does not anpear as such in the

urine of dogs, whatever the route of adrY·inistrstion. (93)
There seems to be no detrimental effect on the kidneys,
and like other aneEthetics, amytal inhibits water diuresis. (94)

The known effects of amytal on laboratory

.s2.

animals are correlated with the more recent experiences
of amytal as an anesthetic in human beings.

Although

amytal his been definitely disappointing as an anesthetic
in physiological research work, yet, when pronerly used,
its

ph~;rmacological

actions may be of no hinderance to

its use as an anesthetic in man. (84)
The effects of sodium amytal on the circulatory system
are somewhat dependent on the 8mount, rate, and manner of
administerntion of the drug.

It is possible by the rapid

intravenous injection of sub-lethal doses of sodium amytal
ln animals to produce death or an immediate fall in blood
pressure to alarming levels.

Lieb and Mulinos, (97)

state that sodium amytal when given intravenously to
laboratory animals, depressed the circulation and produced
a prolonged temporary parB.lysis of the vagus to the heart,
which lasted from one to one and a half hours.
Underwood, and Gaynor, (98) have conflrmed these
reported by Mulinos.

Shafer,
fj_nd~rw,s

Tht::y also four,d the p;reftsst slowing

from stir:mlation of the vngus ; n decerebr.s.te animals and
the least in those just under arnytal, while intermediate
slowing was observed in dogs under ether.

The blood

pressure incre:-ised following stimulation of the vagus
under amytal, Jf the vagus car1"ied a ;;;reater number of
pressor impulses.

Lundy, (87) and others have observed

an incre:· se in blood pressuJ•e in two cases following
the intravenous administr1,tion nf sodium amytal to their
surgical patients.

----------··-·------

53.

As a rule, following t.he intravenous injection of
sodium amytal in man nt a compar&tively slow rate, one
c.c. per mlnute, a decrease in both the systolic and the
diastolic blood pres!"ure occurs, usu&lly durinr; the tlme
the drug is being injected, and hecomes most marked when
the patient loses consciousness.

Mason, Baker, and

Pilcher, (99} reported that the systolic pressure in all
but a few instances fell to an

avera~e

of 30. mm. of

mercury, and the diastolic to an averap:e of 15. mm.
durinp; the induction of anes'hesia, but: returned to normal
levels early in the operation.

Patients with hypertension,

those who are m2rkedly sclerotic, and patients who are
debilit8ted from chronic illness, may show much greater
decreases in blood pressure, even to alarminp; levels and
subsequent death.
James Poe, (5'7} states that because of the possibility
of a greut fall in blood pressure, elderly patients with
~eneral

arteriosclerosis and hypertension are considered

unsatisfactory subjects, &s the fall in blood nressure
may have serious consequences, and hence the dose should
be very much

lim~_ted,

if used at all, in these cases.

Animals given fatal doses of sodium amytal died of
resnirEtory failure, which usually precedes that of the
circulatory system, though failure of both sometimes
occurs simultaneously, particulrrly if the drug is injected ranidly.
iments on animals

Isenberger, (89) in a series of experdesi~ned

to show the effect of narcotics

on the function of resDiration, found that moderate doses
of sodium , m:rtal resulted in a slight decline in the rnte
of respir&tion accompanied bc- a compensatory increase in
denth.
sodium

Small doses of morphine
amyt~·-1

~iven prelimin~ry

to

seemed to render the action of sodium amytal

more uniform as well as more 1ntense, and thus reduced the
amount of both sodium amytal and morphine required.
Isenber~er,

(89) also calls attention to the fact, however,

that morphine may be chiefly responsible for the changes
in the respiration observed after morphine and sodium
amytal have been given in sequence in therapeutic doses;
also, that basal narcosis, as a result of the proper administration of sodium amytal in combination and sequence
with morphine preceding the administration of a generf•.l
Hnesthetic, such as ether, and full surgical anesthesia
with relaxation, were safely and easily established and
adjusted.

At the s&me time, the-r>e appeared to be retain-

ed a definitely higher degree of respiratory reserve than
when ether alone, or ether preceded by morphine Hlone,
was used to a stat,e of similar degree of anesthesia and
relaxation.
Clinical observation of the administration of comparatively small amounts of sodinm amytal for pre-anesthetic
preparation of patients

h~

s been described, and follows

closely that defined for animals.

The respirations

~:.re

usually regular in rate, but are frequently reduced 1.n
amplitude.

There w0 s little che.nge in t:he color of the
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skin, although a sJight degree of cyanosis has been noted.
Mason, Baker and Pilcher, (99) call attention to the
development of a flush of the skin, sometimes resembling
a febrile reaction.
When the drug is injected intrf1venously the induction
of sleep is rapid and quiet.

Drowsiness,.noted by droop-

ing of the eyelids, yawning, and slurring; of words, comes
on after the administration of 3.-9. grains.

These same

authors also noted that as the dose was increased the
oat:Lent became reflexly hypersensitive, and finally entered a profound state of narcosis.

The pupils became con-

trFcted and in some cases fixed, so that they would not
rec:1ct to light.

The corneal reflex was diminished and

the gag reflex remained intact.

The knee jerks were often

exagQ:er< teu during the period of hyperesthesia.

In this

state, patients sometimes became restless, if stimulated.
The period of unconsciousness may last anywhere from
3.-6. hours, depending

U

1

)on the amount of the drug given.

,!!hen a sufficient amount of the drug was eliminated or

destroyed, the patients passed through a mildly restless
period of comparatively short durrtion, in which they
were disoriented, moved aimlessly about, and uttered incoherent statements.

During the

followin~ hou~s

they

continued to be drowsy, and slept at intervals.
L.G. Zerfas, (64) states, "in our earlier work, we
used sodium amytal in apnroximately 100. cases as the
sole anesthetic.

It was soon apnarent that the mi:irked

---
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depression upon the circul.,tory and resniratory systems
carried with it certaln dangers wh 1 ch would not warrant
its

~eneral

use.

The

~reater

pronortion of the patients

were restless and delirious for a period of time, which
added further to the difficulties of its employment es
an nnesthetic agent.

Also there were no clean-cut

criteria for judging the dosage when adm1nistered in such
amounts 11 •

This drug and other barbituric acid derivatives

have been employed in smaller doses to a definite advantage
in the nre-anesthetic preparation of the patient.
Holman and Palmer, (100) state that the occasional
pestlessness and the mild delirium after operP.tion are a
definite disadvantage, but are usually absent when amytal
is administered in smaller doses, ri:-lnging from 7.-12.
~rains.

In their experience with the intravenous admin-

istration of the drug the drop in blood pressure is a
distinct disadvantage.

Even with small doses this drop

may be alarming, and may be sufficient to warrant postponement of the operation.

They think it

of an individual idiosyncrasy to the

dru~,

ma~r

be an evidence

and its

possible appearance makes frequent observations on the
blood pressure during the administration of the drug
imDerative.

They conclude from their experiences

w~th

:tts use in 150. cases of q:eneral surgery, that sodium
amytal provides the normal :1nduction of a natural sleep
without the apprehensive struggling of a conscious patient.
There was noted a marked reduction in the postoperative
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nausea, struggling, and pain.

In operations upon nr,tients

with exophthalm.ic goiter, and upon very apnrehensive,
excitable

p~~tients,

sodium am:ytel

h~,s,

they believe, a

very definite place in anesthesia, and may be used in
doses of 7.-12. i;i:rains with definite advantage to the
patient.
Mason and his associates, (99} using sodium a.mytal
intravenously, called attention to the variation in
individual susceptibility to the drug.

They found that

the minimum dosage required barely to erHse
varied frequently from 3.-9.

~rains,

consciousnes~

illustrating the im-

practicability of estimating the proper dosage.

From their

experience with its use in 305. cases, they concluded that
when the drug was used for the pre-anesthetic preparation
of the patient, with a dose just large enoug;h to make the
patient lose consciousness, it gave: more satisfaction than
any other drug used.

In patients with hyperthyroidism,

Pnd in those who were nervous, it g;ave the most satisfying results.

1fuen the drug was given slowly and the ad-

m' nistration stopped as soon &s the petient lost

conscious~

ness, they considered that no serious or untoward effects
would be experienced.

They sugg;est the followi"g surgical

indications for its use:

hyperthyroidism, and lrparotom-

ies in which jt is desirable to have relaxation with
ethylene; kidney operations, nslng sodium amytal supplemented by ethylene; to produce unconsciousness whereever there is an emotional element of any degree before
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any type of operation; for the control of postoperative
delirium or excitement; and as a pre-operative measure
to promote rest in

hi~hJy

toxic goiter cases.

The uses of this drug for purnose s other thf·in preanesthetic preparation of the Datient, include the control
of convulsions as observed in tetanus, eclampsia, status
epilepticus, strychnine poisoning, and cocaine and precaine poisoning.

It has also been used in controlling

patients with delirium tremens, unmanageable mental cases
and various postoperative psychoses.
In the field of anesthesia, patients who are poor
anesthetic risks lll1lY be considered "1oor risks when sodium
amytal is used for ':ire-anesthetic preparation.

Patients

with hypertension, hypotension, generalized arteriosclerosis
and those who are emaciated are poor subjects for the use
of sodium amytal.

Patients with pulmonary infections,

lung abscesses, and bronchiectasis should not receive
enouP:h of the drug to interfere with the gag reflex, and
it is better

o~

the whole to use very small amounts, 3.-6.

grains, preferably without producing a total loss of
consciousness.

The drug should also be given cautiously

or not at all, following very large doses of morphi.ne, or
in those patients particularly sensitive to morphine and
similar drugs.

The

intrav~nous

administration of the drug

should be stopoed at once if an acute drop in blood pressure or a mhrked decrease in the hmplitude of the respiration occurs.

The intravenous method cHrries with it certain

-
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disadvantages, such as the dangers from too rapid administration, more ac 1te respiratory and circulatory de1

pression, and the technical difficulties and dangers
inherent in intravenous administration of drugs.

However,

the effects are obtained almost immediately; the minimum
amount required for the individual patient may be judged
more accurately; and the rate of elimination or destruction proceeds at a faster rate.

As is well .known, no fix-

ed rule can be used for calculatinp.; the dosage, and
individual variations exist in man.

This one point alone

is sufficient to contraindicate t.he use of barbituric acid
derivatives in large doses.

It is considered, however,

that doses of 3.-9. grains, not exceeding 15.

~rains,

are

comparatively safe limits for the clinical use of sodium
amytal. ( 84)
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PERNOCTON

The desired qualities in obstetrical anesthesia are
those of general anesthesia with important additions.
These additions are: 1. The anesthetic should not interfere
with uterine contractions; 2. If possible, it should permit reflex abdominal muscle contractions; 3. It must not
effect the foetus.

It was the search for a drug that

would fill the above prerequisites that led to the discovery of the barbiturate called pernocton, and until the
advent of pernocton, it could not be said that such an
anes•-hetic, with the partial exception of nitrous oxide,
existed.
The extent of anesthesia is determined by the concentration of the anesthetic in the blood and tissues,
and the appropriate concentration is such that the
cortical cells are depressed, but the medulla, with its
resniratory and cnrdifJC centers, is not so affected. {68)
Pernocton is a 101& solution of the sodium salt of secondary butyl-B-bromallyl barbituric acid.

It is a white

crystalline substance soluble with difficulty in water,
but readily in alcohol.
Animal experiment has shown that acetonyl barbituric
acid is the fragment of the pernocton molecule which is
excreted in the urine, and this renresents only one-fifth
of the amount administered, that is, the remainder is
destroyed in the body.

Moreover, an eniffial CLn be fed

---
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with acetyl acetonyl barbituric acid with the result thet
only a small portion can be recovered from the urine,
pointing to the fact that the molecule can be oxidized
by

the

o~ganism.

(68)

The chemical formula of pernocton is

CllH140~N2BrNa.

It was in•·roduced in E.urope and has been extensively used
there during the last ten years.

It has also been used

recently in this country in both s 1rr:ery and obstetrics
1

with good results.

I
"!
l

It apnears to have an advbntage over

the other bnrbiturBtes bec&use of its early detoxication
within the body, and hence is without the prolonged sleep
and depression that so often follows the use of the other
hvpnot:.c drugs of this type.

Pernocton has also the ad-

vantage of stability when in solution and hence is prepare.l in a sterile solution, ready for immediate use. (57)
Pernocton has been in use in GermErny since 1927. ( 58)
Its advantage over sodium &mytal and nembutal is thr>t it
is st&ble in solution so th1::it no mixing or dilution is
necessary.
Pernocton, by the introduction of the -CH2-CBr=CH2
group, acquires one of the most desirEble attributes of a
good hypnotic, the nro;:erty of ranid decomposition or
Rlteration to non-toxic substances within the tissues.
Ac~ording

to R.F. Matters, (68) one of the most signif-

icant structurhl l:idvEintages is the presence of the secondary butyl radicle which by its asymmetric carbon atom
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sinmlates naturally occurring molecules.

The toxic margin

with P.ernocton is very high; intra venous admi ni strf;tion to
rabbits gives a ratio of 1: 10 for

fl

v·erage narcosis dose.

Intravenous adm:tnistration is desirable in that it
admits of absolutely eccurc;.te dosage and rate of absorption by the nerve cells.

Intr&muscular or enteral admin-

istre.tion is uncertain in this respect and, although
necessary when more dangerous compounds are used, it is
not important in pernocton anesthesia, except perhaps for
additional amount which are given intramuscularly mainly
because of the slower absorption. (68)
Its initial use was tried in asylum nractice, and
the first clinical knowledge of its value is due to Bumm,
head of the Surgical Clinic at the Charite, Berlin,
Germany. (Taken from R.F. Matter's report, (68))

Bumm's

first review of 100. cases begins the literature upon this
subject.

Since then, 1927, until April, 1930, two hundred

thousand cases of clinical administration have been reported.

In giving pernocton, it is very necessary that one

should induce by suggestion a satisfactory mental attitude
in the patient.

The dose of pernocton is 1. c.c. per

12.-15. kilograms of body weif!,ht, the rate of injection
being 0.75 c.c. per minute.
The method of administration now most uni versE.lly
adopted was originally taken from a pB.per by Brammer, of
the Universitats Frauenklinik, Freiburg im Baden, whose
1500. pernocton deliveries have been completed and of

::~

·..__

these he has esnecially analyzed 225. cases to determine
the best procedure.

In the s1:tme paper is given a minute

analysis of the results of pernocton anesthesia as used in
other clinics, and he indicates especially the following:
(taken from R.F. Matter's discussion of the original paper
in German, #68)

"Goldschmidt states th£lt 3.5 c.c. is the

lowest amount that suffices for a case.

Vogt uses 8.8 c.c.

as an initial intravenous injection, and after 45. m5nutes
gives 4. c.c. intravenously, in addition.
are no ill effects.

He soys there

Mutz gives 3.5 c.c. intravenously

and 1.5 c.c. intramuscularly.
lasts for three hours."

He says that anesthesia

Brammer states that using 5. c.c.

of pernocton, it was found that the intravenous route was
many times more efficacious than the intramuscular route;
he considers that the latter has a variable rate of absorption.

He further advises that in primiparae the pernocton

should be given when the os is "five shillings" dilated;
the cervix in multiparae should be dilated only "three
shillingsn.
for the

The averaP::e duration of the "twilight sleep"

sin~le

dose in 72. women was found to be 2.5

hours, e.nd the average duration in

28~

was 1.45 hours.

In 801 of Brammer's cases the anesthesia ll:isted for 3.
hours and the &mnesia was complete.
Matters ( 68) makes the following conclusions:,

1.

Pernocton is a suitable obstetrical anesthetic; 2.

It

has been abundantly tried and fulfills all the requirements of obstetrical anesthesia; 3.

The results he

........

------------....
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obtained corresponded closely with those published in
Europe; 4.

Quiet surroundings and careful suggestion

're essential to the technique; 5.

The intravenous

route is the more exact and suitable method of injection,
while the more slowly absorbed intramuscular injection is
used for additional doses to maintain the concentration of
the anesthetic in the blood.
Friedlaender, (67) states that the psycholog:lcal explanation of sleep ls the theory which best lends itself
to an explanation of the action of pernocton.
be shown later, the method of

~iving

As will

pernocton includes

preparation for hours, even days before the advent of
the operation.

The patient is prepared by sugp,estion

for what to expect and is told how pleasant and harmless
pernocton is.

This suggestion as a preliminary is very

essential, for it induces a state of mind which is the
first step to beneficial sleep. (67)
Pernocton directly paralyzes the receptive ab5.lity
or rather the ability to synthesize ideas and impressions
and thus nroduces narcosis.

The narcosis induced by this

drug is one sten beyond natural sleep, for the individual
cannot be roused by ordinary stimuli.

Pernocton is described

· bv some as a paralyzer of the ability to concentrate on
limited number of stimuli.

Pernocton belongs to the

~roup

of hydrocarbons, all of which possess the ability to produce naroosis in varying degrees of toxicity and effectiveness.

As a general rule, "all other factors being
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equal, the effectiveness of action of a hydrocarbon increases with the len.!:1'.th of the chemical side-chain. 11

6'7)

(

A limit to this rule is soon reached, for the longer the
side-chain, the less volE tile, soluble, and absorbable
the drng becomes.

It can rePdily be seen that an insol-

uble, non-volatile, and non-absorbable drug, no rratter
how powerful it is, is of no use.
Pernocton has an especially effective

len~th

to the

side-chain; not too long as in amytal, where the variation in solubility of different lots is due to the excessive length of the side-chain.

Another factor enhancinr:

the value of pernocton is the halogen replacing one of
the hJ[d:r:pgen a toms. ( 6'7)

Bromine supnli es all of the

benefits of the halogen, at the same time lacking all the
danirerous qualities of the other halogens.

In short,

pernocton, according to its advocates, contains all the
factors making for therapeutic effectiveness and has no
determinate qualities such as undue toxlcity or difficulty
of manaci:cment.
This is really highly debateable and only the opj.nion
rendered by those who champion the use of pernocton.

The

reletively slight toxicity of pernocton as compared with
the other barbitu.rates is due to the rapid decomposition
of the drug in the body.

This same author, (67) who so

strongly champions the use of pernocton, also made the
followin~

statements wh-ich have a bit of a contradictory

air to his previous conclnsions:

"From the beginning of
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our investigations we had in mind the two main factors,
ease of control and harmlessness on one hand, and preservation of the patient's constitution on the other.
Because these two factors were not found in an;r one of
the anesthetics known today, we sought for and obtained
the desired results by combining pernocton with an inhalation anesthetic, preferably ether." {67)
Pernocton's use, therefore, is principally that of
basal anesthesia, or an induction medium, followed by
ether.

With this combined anesthetic, somatic sensibil-

ities Are to a

~reat

extent eliminated.

Complete anesth-

es:ta with pernocton is never attempted by the wise, states
one author.
upon the

The determination of the proper dose depends

wei~ht

and the psychic condition of the natient.

As a rule, 1. c.c. of the

10~

solution of nernocton per

12.5 kgrn. of body weight will be sufficient to put the

patient into a deep sleep in from one to two minutes.
Examinations too painful to the patient to be carried
out without an'" sthesia, E.nd minor surgical operations crn
be made under the influence of pernocton.
been used in cases of

~eneral

sur~ery,

The drug hrs

in operations upon

the thyroid P,land, stom2ch, gall-bladder, appendix,
kidney, prostate, etc.

In 700. cases reported by Bernard

Friedlaender, (67) there was not a s1ngle fntalitv, and in
only 4. cases were there found an excessive a.mount of excitability i'ihich

vm s

beli evsc: to

L.~ Vi'0

bEH'ln duE

to an improper

technique, namely, too rapid in.i ection of the drug.

""
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The method for the intrHvenous injection of pernocton
is as follows:

1.

Pernocton is a hypnotic to be used

intravenously.

If used in ravenously 'in the nroper dose,

instEnt sleep is produced with +-he elimination of all
sensation; 2.

Its principal use is for in&1ction and the

supoort of an inhalation anesthetic and it serves to avoid
all psychical disturbances of the putient; 3.
dose need not be more than 1. c.c. to 12.5
body weight; 4.

The

avera~e

kilo~rams

of

The intravenous injection should be

stopped even if the full dose ha8 not been given; 6.

In

fifteen to twenty mlnutes after the injection, a small
amount of ether may be
ion; ?.

~iven

to t:he patient by inhalat-

The normal sleep after oper&tion may last from

two to five hours, reducing postoperative pain to a minimum.
The conclusions that I reached, after rending most
•

I

of tne available data, which is enormous in amount,
concerning pernocton and its use &re as follows:

1.

-~

Pernocton, in chemical structure, combines +-.he advantap;es
necessary in anesthesia in the possession of « long sidechain and a halog-en replacement of •-he hydrorr,en a tom without sufferinR the disadvantages of similar compounds,
namely, insolubility, toxicity, etc.
duces a state closely

rela~ed

2.

Pernocton pro-

psychologically to natural

sleep, wjth the fidded benefit of rendering the subject
impervious to

extern~l

stimuli.

3.

Pernocton should be

administered in a dosap;e relative to the body weight.

t
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4.

Pernocton should never be adm;nif'tered in doses

great enoui::i:h to abolish the reflexes.

In major operations

it should be used as an extreme hypnotic for induction, and
combined with a small &mount of ether.

5.

Pernocton may

be used effectively as the sole anesthetic for painful
examinations, and minor surgical operations, but the
danger in this sole use of pernocton is great.

6.

The

700. cases with no fatalities and only 4. cases where
extreme excitability was present are seemingly fair evidence
of this drug's beneficient effectivity

NEMBUTI~L

Nembutal, sodium ethyl methyl butyl barbiturate, has
the characteristics of the barbituric acid series more
clearly developed than any other barbiturate.

It is

about twice a.s toxic as sodium amytal, (96) and its
action is much shorter.

Lundy, (96) states that it is

more sedative than hypnotic and thPt it causes delirium
and restless-ness less often than other barbiturates.
Nembutal (Abbott) is supplied in

ampou~es

(gr. 7i) for

intravenous use after being disBolved in distilled water,
10. c .c.

For the inject.ton a 10. c.c. syrinp;e is used with a
fine hynodermic needle, and the solution is injected at
the r::..te of about 1. c.c. per minute.

When administered

intravenously the inject'ion need not be begun until 10.
minutes before the time of operr:tion, for the effect is
qujckly and accurately obtained.

No calculation of dose

on a body weight basis is necessary, the amount being
determined by the progressive effect during injection.
The solution should be freshly prepared and quite clear.
The injection should be carried out &t the rate of about
1. c.c. per minute, a close watch
p:··.tient throughout.

bein~

kept on the

The patient's response to questioning

becomes gradually more 2nd more indistinct and without any
period of excitement, the patient p8sses into.a quiet
sleep.

The dose is the minimum amount necessary to
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produce this effect aft r:r slow and careful injection.
The minimal dose in Magill's series of clinical cases, (66)
was grains 3. and the maximum was grains

'7i.

When sleep

ensues after intravenous injection respiration is quiet,
diminished in amplitude, and normal in rate.

It hi:is been

stated by some that a fall in blood nressure takes place
during the injection of a barbiturate, (85) but other
exoerimenters such as Magill, (66) find that with nembutal
the fall in blood pressure is trivial or absent in '11
their cases.
During the course of the operation after :i.ntravenous
injection t.he amount of the sunplementary anesthetic required is less than with oral or rectal administration.
This, says Magill, "is clearly the result of the more exact
dosa~e

by the intravenous route."

And, perhaps it is due

to this more accurate dosage that a survey of literature
reveals that the post-operative effect following intravenous injection is more marked than with oral or rectal
administration.

Drowsiness or sleep from 1.-5. hours

after operation is the usual course, with hazy memory for
events dur:lng thb.t period.
In order to compare the results obtained with other
barbitur0tes, I.W. Magill, (66) administered sodium amytal
intravenously to 23 cases, and pernocton to 15 uatients.
All of these uatients were adults.

Induction of pre-

onerBtive sleep with sodium amytal compared favorably
with nembutal, but the recovery period was much longer.
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Pernocton has heen reckoned eau;l to nembutal in toxicity,
and the recovery neriod was about equal. (95)
It is in the intravenous use nf nembutal that the
gre~test

lies.

advantage over other methods of administration,

By this method it is possible to determine the dose

accurately during injection of the drug.

Here, ap;&in, the

reaction of the patient seems to bear little relation to
age, body weight, or habits.

Intravenous injection of a

drug in connection with anethesia is open to criticism as
an unnecessary complication not unattended by danger.

If

injection is carried out carefully and slowly, with aseptic precautions, it need involve little more risk, and
certainly no more discomfort, than a hypodermic injection.
From the adult patient's point of view, a prick with a
hynodermic needle is usually expected before an operation,
2nd to many it is more acceptable than the retention of a
rectal injection of any kind.

Intravenous injection of

nembut&l is a vaila~le, f 1irther, 'Nhen rectal premedication
is ruled out by the nature of the operation.
a minimum of ap-oaratus and preparation.
might se,,..ve to summarize the subject:

It requires

The followlng
I.

Intravenous

injection of nembutal provides a pleasant method of
bridging the gap between consciousness and unconsciousn~ss,

before general anesthesia.

2.

The amount of

anes; hetic subsequently required is diminished.

;-s.

Post-

onerEtive nausea Bnd vomiting are diminished or 8bsent.
4•

The chief disadvantage is

postopers~ive

restlessness

-------------
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in s. small percent<:ge of cases, about 10%. (95)
It hbs recently been well established that there is
great

v~riability

in duration of the sedbtive and hypnot-

ic actions of different members of the bbrbi turic acj_d
series.

As regards hypnotic action they have thus been

arbitrarily divided into "long-acting" and "short-acting"
barbiturates.
imytal) is a

Sodium iso-amyl-ethyl b1°rbiturate, (sodium
~ood

example of the first, and nembutal may

be taken as typical of the short-acting barbiturate
hynnotics.
In

sur~ical

cases experience of a good many has

proved that a short acting barbiturate, having a brief
hypnotic c.ction, is safer and more satisfactory than long
acting barbiturates.

In general, Volwiler, (59) says,

the long acting barbiturates are antispasmodic and hypnotlc with a durable hypnotic action; the short actj_ng ba.rbi tura tes are antispasmodic and sedative with hypnotic
2ction of short du:r'ation but of sufficient length to cover
the

~eriod

between administr&tion and the induction of

surgical anesthesia as well as of the operation itself.
In medic.:l cases, he points out,

~

short act:lnp; hypnotic

ts often prefera.ble because the hypnotic effect is still
long enough to assure hours of rest for the

p~'itient,

yet

the nroduct is eliminated so rapidly that there is much less
likelihood of "hangover", more commonly exoerienced after
the long-acting barbiturates.

Furthermore, the barbiturates

of the short acting series are characterized bv the fact

that a smaller dose produces a very tntense if more fleeting act:ton.

This means a more rapid elimination

~nd

a de-

creased tendency to any possible toxic or other undesirable effects, with a wider m1rgin of safety.
'Nhile in laboratory animals r;eneral surp;ical anesthesia has been induced successfully by the employment of
barbiturates alone, a resume of the literature shows that
clinical attempts have not been uniformly satisfactory
for the human subject.

The general opinion of clinicians

is that the barbiturates find their field of usefulness as
hypnotics and as pre-anesthetic sedatives.
A pharmacolo~ical

report by Fitch, Waters, nnd Tatmn,

(95) covered an accurate laboratory and clinical comparison
of sodium amytal and nembutal, as well os the German preparation, pernocton.

These investigators, (95) found that

to produce sleep in an ordinary previously morphinized
jndividual, 0.6-1.4 grams of amyti;_l, 0.4-0.R grams of
pernocton, and C.2-0.5 grams of nembutal were required.
They also found th1- t both the period of postope:rative
sleep and the postoper1.:J.tive excitation were distinctly
less with nembutal than with the other two barbiturates.
Dr. Johns. Lundy, (87) reported clinical confirmation of the pharmacological observations of Fitch,
.Vaters, and Tatum. (95)

1

Based on his observations on

several thousand cases in the Mayo Clinic in which
sodium amytal or nembutal were employed he found thnt the
latter is essentially an antispasmodic

and sedative,

J

with lesfl delirium incident to its use than with the
former.

Moreover, it is twice as effective, thus per-

mitting smaller dosage, and the period of recovery is
only half as long.

Dr. Lundy, (87) concluded that the

nembutal is particularly advantageous in obtaj_ning preoperative sedation regardless of the final anesthetic
used and in cases in which it is desired that the barbj

I
I

turate effect should be of short duration.

Barlow,

( 86) in experimental work on re rs has found that premedication with 22.5% of the lethal dose of nembutal
intensified the anesthetic prope "ties of nitrous
oxide.

He, ( 86) concludes, "correlation of the p:remed-

ication values of avertin and the nine barbituric acid
deriv<ctives indicate th&t the order of efficiency from
high to low is as follows:

nembutal, avertin, dial,

allonal, neonal, phanodorn, pernocton, luminal, amytal,
and barbital."
Dr. I.W. Magill, (66) admlnistered nembutal as a
be-sal hypnotic to 262 surgical pa ti en ts, the intravenous
route being used.

When nembutal is administered intra-

venously the effect is rapid, says Volwiler; (59)
responses to questions gradually become more indistinct
end, without any period of excitement, the patient passes
into a quiet sleep.

None but a trivial fall in blood

pressure was observed by Dr. Magill, (66) in any case
in which nembutal wrs administered intravenously.

By

the intravenous method the amount of supplementary Fnesthetic
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required was less than with oral or rectal administration;
also the postoperative sequelae were more marked following
intravenous than following oral or rectal administration.
Some degree of restlessness postoperatively was noted in
only VS cases.

Dr. Magill, (66) regarded nembut:al es the

most outstanding anesthetic

dru~

i'nd one sure to be of

great value in med:i.cvl practice, i.e., in epilepsy,
convulsions, eclampsia, delirium tremens, hysteria nnd nny
nausea.
In discussing Dr. Magill's paper, Sir FrEncis Shipway,
(104)

s~id

that there seemed to be a

~reat

future for

nembutal; he we s using it constr"'1ntly and saw no di sadvantan:es from its use.

Dr. Sttlnley Rowbotham, (105)

unhesitatingly endorsed Dr. Magill's conclusions in regard
to nembutal.

He has

administe~ed

it in 108 cases and

st&-t,-s that comp1c red with his experience with sodium amytal
1

and pernocton there is no doubt th&t it is the best of
the three drugs.

In the majority of his cases there 'Vas

a fall of 10.-15. rrnn. in the systolic blood pressure with
nembutal whereas with amytal, the fall was usually double
this amoi..mt, and postoperetive restlessness was decidedly
more mE1rked.
we~e

With pernocton, he reports that the results

even more unsatisfactory.

states that as

B.

Dr. Jas. Riddell, (106)

ureliminary sede.tive in nervous pRtients

he found nembutal valuable and easier to employ than avertin
per rectum.

In his expe!'ience also it ls preferable, in

obstetric practice, to sodium arnytal, intravenously or
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orally.
John D. Graham, (107) states that the advantages
possessed by nembutal are minimal

dosa~e,

more rapid

elimination, greater freedom from after complications, and
less tendency towards extreme restlessness or delirium.
However, valuable as the drug is intravenously, in
gynecological surgery, he states, it like other intravenous drugs has no nlace in obstetr:tcs, but is very
effective and efficient in this field when given intramuscularly.
John

s.

Lundy, (6) in his report on nembutal states

that it is definitely sedative, antispasmodic and, of
course, hypnotic.

He reports a series of 2,300. cases

in which nembutal was used intravenously to produce
anesthesia.

In this series 0.5 grams of nembutal was

first dissolved in 7.5 c.c. of water so that the concent~ation was one graln per c.c.
WBS

For adults the solution

injected at the rate of 1. or 2. c.c. per minute.

The effect of the fjrst gr&in was hardly anparent.

After

two grains were given the patient spoke of a definite
effect; after three p;rains there was a general feeling of

ri

neFce and well-bejng; after four grajns, the patients
usually fell Psleep but were not anesthetized; after five
greins the petients were more deeply asleep but not anesthetized; after six grains the patients were in begtnning
anesthesia; after seven grains anesthesia was usually
ap"'arent and after seven ;end one-hal:f-grains there were
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few cPses in which anesthesia was not comolete.
Geor;;i:e Carroll, (5) champions the use of nembutal as
a sedHtive for

prelimin~ry

and spinal anesthesia.

medication to local, general

He states that in preparing the

patients for operation, as in emergencies, accidental
and traumatic injuries, the rapid effect, small dosaRe
and short duration of effect is advantageous.
while nembutal is not -intended as

&.

Also,

lone anesthetic,

properly graduated dosage will produce a degree of anesthesia under which much can be done without additional use
of other agents.

He, (5) states that in properly select-

ed cases under skillful manipulation, extensive surgery
may be done with the employment of locEil infiltration or
a very small amount of inhal1ction anesthesia.
in local and spinal

~nesthesia

Its use

has been found to raise

the toleN1nce to normal and reduce to a minimum the
liability of disagreeable reactions and sequelae, and
the recovery period is rapid, due to the small amount
of &nesthetic required, and is usually unaccompanied by
nausea or vomiting, with a period of sedation li:sting
several hours.
I

r

r

I

Where time is an element of consideration, this intra-

~·

venous method is most satisfE;ctory.

I

(5) considerable lattitude in dosage was found necessary

l
t

According to Carroll,

due to the j_ndividual reaction, where effectiveness

WES

observed to v~:ry with age, and general physical condition
and the dose required to produce sleep was best determined

I
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by the rate at which the subject became unconscious.
re~ards

As

the nembutal solution itself, he points out that

the solution should be freshly nrepared for eRch case as
it hydrolyzes in aqueous solution, and only perfectly
clear solutions should be used.

In his cases, there has

heen no nauseH or vomiting, the blood pressure frequently fell slightly at first, only to return to the previous
level or above in a short time.

The resnirations became

lessened in amplitude, the rate slowed, but no cyanosis
was ever observed.
The contraindications are, as :tn P'eneral anesthesia,
the

a~ed,

high or low blood pressure,

arterioscle~osis

and unstable cardio-vascular systems, pulmonary involvement or edema about the neck or throat.

Carroll, (5)

states that the chief dangers are broncho-pneumonia, and
postoperative pulmonary edema, but th::;t these are noted
only after excessive doses, and that nembutvl should not
be given 6fter large doses of morphine, nor should it be
given except in smaller doses in the presence of known
kidney impairment.
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EVIPAN

As the chemists of the firm Riedel did not succeed
at the time, in spite of indefatigable efforts, in removlng the exciting properties of the anesthetic pernocton injection, by modifying the nnture of the solvent,
it was, as a result, taken for G'.rEmted that the excitation of reflexes was a property of all brrbituric acid
derivatives, so that we had practically given up the
hope of finding an injectable anesthetic suitable for
practic::,l use.
Nevertheless, Weese (44) succeeded recently in discovering evipan-sodium, a derivB-tive of barbituric acid,
which does not nossess the undesirable properties of all
injectable anesthetics known up to now, particularly those
of amytal and pernocton; on the contrary this new product
shows a considerably s:;reuter solubility, as well as the
property of a more complete

splittin~

up and decomposition

of its molecule within the organism.
Evipan-sodium is the sodium salt of evioan, i.e., of
N-methylcyclo-hexenyl-methyl-barbituric scid, which latter
substance we_s produced by Kropp and Taub, and was introduced at the time by Weese.

Weese, (44) reports that in his

exneriments with evipan, he was impressed by the most striking fact that in

comp<~rison

with other derivfatives of barb-

ituric acid, this particular one caused an extraordinary
rapid and deep sleep withovt after-effects-and without
causing any symptoms of excitement.

Weese also noticed

at the time, that the margin-between its minimum anesthetic
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and toxic doses is very large and that only several
Bnesthetic doses have a fatal effect.

On the bH sis of

these observations, efforts were mede to create an
injectable anesthetic for the purpose of short anesthesia,
which resulted in the nroduction of a sodium selt of
evipan.
Evipan-sodium, also called endorm, is a whitish substence readily soluble in water.

Organic sol vents have

also been found recently, in which evipan keeps permanently. (44)

The manufacturers state for instance that the

evipan .concentrate represents a
ium salt in methyl-diglycol.

33M6
,

solution of the sod-

Consequently, there was at

first, for practical purposes, two different kinds of
ampoules, i.e., 1. Ampoules containing a definite weight
of the sodium salt, for the preparation of a 10% aqueous
solution.

2. Ampoules containing a

33t%

solution of

evipan-sodium dissolved in methyl-diglycol, which had also
to be diluted before use with 10. c.c. of sterile water,
so as to obtain a 10% solution.

The latter form is now

the usual form, and the one that is used commercially.
Weese, (44) seems to

h~ve

searched from the very

beginning for a product for producing a short general
anesthesia by injection.

In feet, he directed his

attention mainly to the rate of decomnosition of the said
substronce.

As a matter of fact during the lH st few years,

both phhrmacologists and clinicians have realized that
the elimination of an anesthetic agent calls for very
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careful consideration and represents a much more importBnt factor when considering the apnlicability of a preparation than the factor of the difficulty of absorption
by the circulation.
The curve of evipan-sodium anesthesia, is similar to
that of all injection anesthetics, and as sh0wn recently
_by Rehn and Killian, (45) for pernocton in their critical
survey of our an sthesia processes, the rising is very
steep and depends not only on the concentration and on
the total dose of the product, but particularly on the
rate of injection.

If this is made with

the anesthesia curve runs
~ives
i

I

I
I

I

~

mode~ate

speed,

n such e. manner that the action

the me?:csure both of the speed of the injection and

of the dose injected.

However, the culminating point of

the depth of sleep and the anesthesia curve is always
attained after the end of the injection, i.e., after
from 5-10 minutes a point if reached which must be taken
into consideration.

On the other hand the downward curve

of evipan-sodium anesthesia, when compared with that of
other barbituric acid derivatives, is extraordinarily
rapid, so that both experimentally and clinically, when
using medium doses, one may reckon upon the awakening of
the patient after 15-30 minutes.
The liver must be considered &s the principal detoxicating organ, seeinp; that experiments have shown that
hepetectomised animals, or animals which hPd been poisoned with phosnhorus and whose liver was consequently very

damaged, awoke much more slowly.

According to Weese, (44)

evipan-sodium is hardly destroyed in the blood, the kidneys also do not participate in the process of detoxication of chem5.ca1 decomposition.

He found traces of unchang-

ed evipan-sodium in t.he urine.

Animals which had been

submitted to repeated anesthesia over a period of several
months exhibited no manifestations of tolerance, nor .could
?ny injury of the organism be observed.
The exceedingly good results obtained with animals,
encoura~ed

the experimentul application of evipan anesth-

esia to human beings.

Evipan-sodium anesthesia has been

used bv one author alone, H. Killian, (44) in over ten
thousand cases without any certain case of death having
become known.

Generally speaking, everything th8t has

been learned rep;arding evipan anesthesia when applied to
animals, has been confirmed with human beings.
The

packa~es

intended for use in clinics contain

each, two ampoules, i.e., a small ampoule with a quant:tty of dry evipan-sodium or with evipan-sodium dissolved in methyl-di_g:lycol which is just sufficient, when
mixed with the 10. c.c. of sterile

wat~r

contained in

the lFrger ampoule to make the solution ready for use.
The _technique of the injection is extremely simple and
requires no special preliminary knowledge.
im:oort<·nt point is the difference
injections of pernocton.

P..S

The only

compared with

Seeing that evipan-sodium

is much mo ·e soluble and much more easily decomposed,

- - - -----------------

- - - - - - - - - - -

it is not necessary to

rr~intain

such a slow rate of inject-

ion t,s in the case with pernocton.

On the contrary, ex-

perience has shown that, when inducing evipan-sodium
anesthesia, it is

pos~dble

to influence the duration

of anesthesia and the depth of sleep by an adequate
rate of injection.

The indications of thE: various authors

show that they hav"' not B.11 carried out the injections in
the same wny, but th&t there are slight differences.

11.t

the start, the firm that manufactured this product, set
down a fixed rule for dosc-.ge on the kilogram per body
weipp_t scale.

However, all those who have taken up the

new method and ha v~; expressed an opinion, agree that it
is neither desirable nor necessary to fix the dose in
rel&tion to the bodyweight of the patients.
H. Killian, (44) adopted the method of detern1·inlng
the dose according to t.he anesthetic effect.
a maximum dose for a single injection.

He gives

Thus Ernst

never exceeds 9. c.c. of evipan, whereas Baetzner
mentioned 10. c.c. as t1:1e highest permissible dose
per injection.

Only Holtermann, (44) who llkewise

conside2:·s 10. c.c. as the normal maximum dose, has,
at different times, injected, in indi1ridlH.l cases,
15. c.c. of tb.e 10% solution without ever having ob-

served any visible damage.

Other workers are said to

have injected even from 30.-60. c.c. without any harm.
l''or an f,.verage evipan anesthesia, in 'Nhich sleep
nmst last from twenty to thirty minutes, in order to

------------------
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8dapt the rate of injection to the purpose, about 3.-4.
c.c. are in,iecte'i in the first mtnute
p~tient

dur~ng

which the

quickly falls asleep, and an additional 3.-4.

c.c. A.re injected fractionally, in such a V'1ay that the
respirs.tion and color of tr1e sidn are not ma.terially
modified during the injection.

The total dose required

for every individual d§se is adjusted during the injection
in accorde.nce with the depth of sleep, i.e., the injection is simply stopped when the operator has the impression that the pr:...tient•s sleep is deep enourrlJ..

Naturally,

the dose is regulated in E-ccordance with the physical
condition and the age of the patient.
Injections have been made in patients

sufferin~

from

diabetes, from dise&ses of the heBrt, lungs, liver and
kidneys without any undesirable effects so that one can
conclude that evinan constitutes a preparation which is
p~

rticult'.rly suitable for patients who are seriously ill.

(44)

In these cases, evipan anesthesia replaces especially

the strong inhalution anesthetics, avertin, regionr.l and
spinal anesthesia; it also r'=·places gas anesthesia with
ethylene or narcylene when dea.lj_ng with arteri.o-sclerotic
natients or typnotic subjects.
If it is desired to use evipan only with a view to
initiate a.nesthesia with other anesthetics, such i:;s gas,
ether, chloroform, remarkably small doses will render the
patient unconscious.

Three to four c.c. o.f the original

solution are often sufficient even with patients of a
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strong conRtitution.

Furthermore if j_t is simpl:r desired

to perform to a short operation, such as can be carried
out under ethyl chloride anesthesia, it is recommended
to inject a small dose of evipan comparatively quickl;r
i.e., 3.-5. c.c. within one n:inute, observing closely
the patient's respiration.

The above dose passing quick-

ly into the blood stream, produces within a surprisingly
short time a depth of sleep

correspondin~

at least to

the first section of the tolerance stage. (44)
The distribution of this comp&ratively small dose of
evipan in the tissues and its decomposition take place
so rapidly that after five minutes, alrei:1dy the quantity
present in the blood is no longer sufficient for anesthesia.
Consequently this mode of application of evipan makes it
possible to obtain a light anesthesia of three to five
minutes duration, which, in contradistinction with anesthesias of the same degree obtained with gas or ethyl chloride,
causes no unpleasant subj ecti '-Ie react ion vrhatever for the
prtient, with exceution of the injection itself, and
contrary to what happens with gas nercotics, the patient
remains in a slightly drowsy condition for about an hour.
The cases of cessation of respiration observed
occasionall;r with evipan anesthesia nrust probably be
attributed to the preliminary administration of lnrge doses
of mornhine or similar active products, a fact which has
escaped the attention of some

observe~s.

(43)

As evinan

anesth2sia is not only complete, but sets in within a

--
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very short time without discomfort for the patient,
there is not the slightest reason for influencing pure
evipan anesthesia by the use of alkaloids.

The admin-

:i st ration of a preanesthetic agent h• s also been abandon-

ed by most clinicians
Holtermann, (44) gives the most exact description of
the symptoms of evipan aneEthesia.

After evipan inject-

ions the respiration as a rule does not remain at. 1-he
normal level, but as the depth of sleep progresses, the
breathing becomes simultaneously slower and somewhat
deeper.

According to the clinical measurements, during

the period of increasing anesthesia a transitorv depression of the respiratory activity takes place, which increo.ses with the speed and volume of the injection.
with all preparations of tht:.t nature, it

fi-~st

As

manifests

itself by a diminution of frequency which is compensated
by a deepening of the successive respiration with a
comparativel;r swift fall of the functional activity
which in many cases caused slight cyanosis or even a
temporary failure of the respir1°tion of a non-danrzerous
character,

The modifications of the respiration are there-

fore the best guide for correcting the sneed of injection.
After the respirfJtory depression which takes nlace during
the first few minutes, that function is usually soon restore& and a moderHte hyperventilation may take nlace
during the second half of the anesthesia.

8'7.

The blood pressure falls during the injection and
generally returns to a level which is 5.-15. mm. of
mercury below the original figure, thus practically never
causing any great anxiety.
deuends entirely on the

ra~e

The falling blood nressure
of injection.

The quicker

and more carelessly the inject ions are mrtde, the deeper
is the initircl fall.

As in the case with all such anesth-

esias, the pulse rate increases somewhat, simultaneously

w1 th the modifications in the blood pressure; the average
ircrease as given by Holtermann, (44) is from 10-30 beats
per minute, but according to Killian, (43) the pulse rate
generally fHlls e_gain somewhat when the tole •·ance

S

4

age

is re11ched and goes back to approximately the normal rate

'l

according to the nature of the intervention.
Generally speaking, only very seldom have complications
been observed in the use of avipan.

Only on a few occasions

have disturbances of the respirations been observed at the
end of the injection, these being probably due to a too
ranid injection into oversensitive subjects.

Baetzner, (44)

reports that in isolat0d cases, after completion of the
injection, the face of the patient became bluish and the
respiration shallow, a condition however which quickly
passed off.
Up to the present time, evipan anesthesia has tw.inly
been used for light an<?sthesia or short anesthesia; snd
only to smaller extent for full anesthesia in cases of
sur~ical

interventions of average severity.

In complete
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agreement with the views of most clinicians, Ernst, (44)
emphasized th&t its slight influence on the circulation
and respiration, as well as its comparative harmlessness
as regards liver and kidneys, permit of its use to the
widest extent; that generalanesthesia with evipan is now
possible with old patients with damaged

he~rt,

in whose

case surgeons hesitated up to now to use other- methods
of anesthesia.
liver

hav·~

Disease of the excretory organs

~nd

of the

not disturbed up to now the favorable course

of anesthesia., nor hns the nnesthes:i.a h2d any prejudicial influence on the course of the disease, even when
the same patients have been subj ecter.'l repeatedly to
evipan anesthesia at short intervals.
As no symptoms of habituation appeared, evipan
anesthesia according to the experience of all authors,
f

can be resorted too as often as desired and can consequently be repeated without danger on the same patient.
Evipan anesthesia is used mainly for short anesthesi_a
or fo.r the inducement of full anesthesia with gas or a
mixture of pas and ether.

An exact specification of

indications has not been possible up to now, seeing that
-~

ion will be necessary with oatients wlth diminished
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respiratory surface or otherwise impaired ventilation;
Also, in the case of sub-uremic patients or subjects

I

suffering from severe liver affections.

The only in-

fluence on the field of indications ls in regard to the
duration of sleep, j_f, for the above mentioned reason, it
is not desirable to make use of additional doses.

It

cBn a.t any rate be stated that, p.;enerully speaking, evipan
anesthesia replaces light and protracted ethvl chloride
anesthesia, also solesthin anesthesia, light ether anesthesia, short ether anesthesia, and to a certain degree also
gas anesthesia.
If we now summarize all the data relatinP: t.o the new
preparation, we can asFert that evinan takes a preeminent place in comparison with all the injection preparations of the barbituric acid class useci un to now, on
account of its being easily soluble and of its repid decomposition, and that it will gain a predominFnt influence
in the field of anestheBia.

Whether it will supplant

entirely pernocton which produces a considerably longer
sleep of lesser denth, remains an open question for the
time being.
The statistics which have been compiled up to now
include over 15,000. cases in which evipan has been used
mainly as a light or short anesthetic with only one certain
case of death.

These statistics are so extremely favorable

that one cannot only recommend the method with conviction,
but can predict a great future for it in all of the fields
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in wl--dch short, or light types of anesthesia are desired.
In conclusion it may be said that e'rinan affords an
excellent, quick a.cting anesthesia for short operations.
Likewise, it is a reliable induction anesthesia for major
operations.

The smaller amounts of the added anesthetic

then used to deepen the narcosis is an advantage.

Evipan

can be successfully combined vdth ether, nitrous oxide,
local or lumbar anesthesia.
ulete

sta~e

The evipan affords a com-

of tolerance, its action is short and certain,.

the nost-anesthetic sleep is short, bad after effects are
rare, its action is safe if the contraindications are
observed, and the technique is simple.

If evipan is

properly used and with the caution advised by those
clinicians acquainted most closely with it, one will
only be able to reccommend it. (44)

M. Babcock, (81)

does not se m to be of auite the snme opinion as to
0

the contraindications, and states that the contraindications for its use are so definite that he believes
it will find but a limited field of usefulness.

Hypo-

tension, severe pulmonary infection, heart lesions, and
pEit:leni· 1 s suffering from wasting diseases, he thinks
should not be given evipan.

Che.s. F. Hadfield, (80)

states that he hhs tested out evipan, and found it
quite favorable and issued such a report.
th~·t

He also states

evipan hns been well received after much thorough

discussion by The Joint Anesthetics Committee of the
Royal Society of Medicine.
- '·

- I
I

L:i eber, ( 23) states that

91.

the drug evipal, is new only in the sense that it hns only
recently become availahle in this country.

He says that

it has, however, been extensively used abroad, and in two
years from the time of its isolation by Kraft and Taub,
it hEd been administered well over 60,000 times.

All

of this work, seemed to him to show that this drug was
indeed one of the most valuable anesthetic agents known.
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NEWER BARBITURATES

4
l

Increase in the nse of Intravenous anesthesia has
been delayed because of lack of a suitable agent, but at
times when a general anesthetic is needed the intravenous
method is the best; (20) for example, if the cautery or.
diathe1•my is to be used, and thus an inflammable a.o:ent
would be dangerous, or if portability is of importance.
For intravenous anesthesia the barbiturates, particularly, h&ve been employed. (8?)

It was stressed by Lundy, (AS) and others, that
nembutal was different from the other barbiturates in
common use, ln th&t it w&s a relatively shorter acting
drug.

Then, still shorter acting barbiturates were

sought, and most of what follows will deal with two
of the newest barbiturates introduced quite recently
by John

s.

Lundy and his co-workers.

In 1934, Lundy (20) began to use a still newer
type of barbiturate, sodium ethyl 1-methyl butyl
thiobarbituric acid, employment of which was attended
by .fair relaxi:.tion, short anesthesia, quick recovery,
and absence of restlessness in almost all cases. (20)
With the exception that oxygen is replaced by sulphur,
this agent is ·the same as nembutal.

This druo.: is

apnroximately 33-50% stronger than evipan.

It comes

in an ampoule, together with a companion ampoule of
sterile water.

The solution used is 10%, and must be
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clear.
Another barbiturate, sodium allyl secondary butyl
thiobG.rbituric acid, referred to elsewhere as "barbiturate
B", has been used in a few cases with results similar to
those obtained with sodium ethyl 1-methyl butyl thiobarbi turic acid.

To avoid the long chemical names, I shall

revert to terms used •lsewhere and already mentioned in

t

this paper; thus, sodium ethyl 1-met.hyl butyl thiobarb-

lf

·l

ituric E.cid will be called barbiturate B.

I

!

barbiturate B is less potent than barbiturate A, it is

l
I
~
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t
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Although

l
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!

't

about as potent as evipan.

!{'

iturate A to barbiturate B in surgical cases for the

~

l

Lundy, (20) prefers barb-

same reason that he prefers nembutal to sodium amytal
for surgical cases; because he wishes to use a minimal
amount of drug to produce a given effect, anticipating
that, .at. leastin the average patient, the effect will
be characteristic and that in the unusual case, fewer
varhitions will be noted ths.n if a larfter quantity of
another drug

h~,d

been given.

The method of giving barbiturate A and barbiturate B,
resembles that used in giving evipan.

An

empty stomach

is desirable, if not essential, and if the nE:ttient has
nY·terial in the stoffiach, it should be emptied.

To ad-

minister barbiturate A safely, the dose is two-thirds
to a half as much &s the dose of evipan.

In adrninis-

tra tion, the airway must be kept patent.

Respiration

may be depressed, and it is not sufficlent to see the
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resniratory movements; there must be evidence of respiratory
exchange.

Lundy, (20) puts a wisp of cotton over the nose

and mouth and observes its motion.
The

advanta,~e

of these short-acting barbiturates

over other general anesthetics, and over certain local
anesthetics, is in proportion to the brevity of the
operation.

Operations or painful procedures, especially

minor ones, lasting up to ten or fifteen minutes, are
satisfactory fields for these drugs. (20)

F'or ambul-

atory pstients undergoing distinctly minor operations,
local anesthesia may be preferred.

If the operation is

of longer duration or is a major one, it is only in special capes thl:' t these short-acting a'J'.ents
useful.

E~

re pc.rticularly

For example, barbiturate A has heen used quite

satisfactorily to produce anesthesia for three and a half
hours, in a case of brain tumor complicated by pulmonary
tuberculosis.

Although, according to Lundy, (20) thirty

four and one half grains were given, there were no ill
effects.

A Magill intratracheal tube provided an air-

way; it also furnished a means of artificial ventilation,
and of administering an anesthetic by inhalation, if these
had become necesFary.
Barbiturate A is useful in small doses, to produce
unconsciousness for induction of anesthesia by inhalation,
particulf' rly if patients h8-ve facial dEo'fects.

Short

<"'.Ct-

ing barbiturates are indicated for intravenous ad.ministration to control convulsions induced by local anesthesia.
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Lundy, ( 20) se<:>ms to differ from a great many other
workers, in his opinion of the value of pre-mediccition.
He states that he has found it advantageous to give
mornhine hypodermically, and nembutal by mouth, in small
doses, to adults, preliminary to administration of the
newer barbiturates, especially in the use of barbiturate B.
With barbiturate A it is less important to give preliminary
medication, because of the increased potency of the drug.
He states, however, that less of either drug will be needed if prelimini:'ry medication hi: s been given than if it
has not been

~iven.

He cites rhe example of patients,

who have had morphine, nembutal and atropine

a~

medication

before administration of barbiturate A, a'Nakening in the
course of the operation, giving no evidence of pain at
the time, and answering questions readily, and then having no memory of either pain or the questions afterward.
This maintenance of analgesia in the nresence of return
of consciousness was not noted in all cases in which preliminary medication had been given, but was never noted
unless preliminary medication had been given. (20)
The patient does not perspire when these new agents
are used and, in some cases, the:ne has been noticeable
absence of postoperative shock.

The blood pressure falls

when a ler.o.:e dose is administered.

The patient, accord-

ing to Tovell, (11) usually awakens quietly and there is
seldom any nausea or vomiting.

Also, he states that as

the drug is given intermittently, the effect following
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administration of each successive dose is increased.

Un-

consciousness produced by a large dose is of long duration.
These newer barbiturates, are of such compFratively
recent origin, that extensive literature concerning its
use, and efficiency are not obtaina9le.

Not enough work

has been done on them, at present, to warrant a logical
decision as to their applicability to clinical medicine.
For this reason, I am presenting them only as an example
of some of the results obtained by those who are in a
constant search for a new ideal drug, which when given
by the intravenous route, will produce an anesthesia of
the most desirable quality.

The ideal agent for routine

intravenous anesthesia has not been found,

['S

yet, but

the available agents have been found by most, to be
satisfactory in certain types of cases.
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Among clinicians, there is a CTreat deal of interest
in this question of intravenous anesthesia.

Inhalation

anesthesia has been brought to a high state of usefulness;
locfi 1 and regional anesthesia too,

hr~ve

been so perfected

that they are useful and safe, and rectal anesthesia by
the use of avertin, has advanced also.

Intravenous

anesthesia, using ether in saline solution, has remained
undeveloped.

The

long-actin~

barbiturates were not safe

because they produced restlessness that sometimes was
difficult to control and tended to produce pulmonary edema
end bronchopneumonia.

Now, we hhve drugs that nermit

quick induction of anesthesia by the intravenous method
which, in some cases, also produce analgesia.
Despite all of the improvements &nd progress that has
been made in the last twenty years in the field of anesthesia, surgeons, chemists and pharmacologists are still
seeking the ideal anesthetic.
discussed

dru~s

None of the previously

quite fit the picture or measure up

completely to the stFndards of this acme of anesthesia.
No single standard csn be held up as the requirements of
the ideal drug, but after a

perusE~l

of various discuss-

ions of this subject, I have attempted to c omnile an
r-'rbi trary set of stf1ndards.

In relieving the patient

of pain and mental anguish during the ope,,..ation, the
ideal anest !etic will not bring added terrors of its own.

The patient will not remember the anesthetizing process
as a hideous nir:htmare, and the worst part of his operative experience.

The postoperative nausea of ether still

remains one of the most revolting memories that the patient
retains.
Secondly, the ideal anesthetic will induce anesthesia
as gently, as quietly and as naturally i;s sleep itself.
No longer will the patient be plunged into a seemingly
endless eternity after a short period of consciousness,
and therefore terrifying, struggle against suffocation.
Thirdly, it will be an anesthetic without irritation to organs of the body in its adm:tnistration and
elimination.

It will not add to the hazards of the

operation by inimical effects of its own such as ether
Droduces in the air passages, chloroform upon the liver,
~nd

cocaine upon the nervous system.
After a thorough inve stlgh t

~.on

of +:hL-' p:... obla:_ of'

r ~'."'-e:r.J. ti:·.c anesthesla thro•ish thi;.J enployment of the

intravenous route, and after reading articles, pro and
con, sponsored by enthusiasts of ehch side of the question,
I have, myself, rather reached an non the fencen attitude,
and although I definitely am of the belief

thc:+~

anesthesia

solely b;T this route, is not at present a plausible idea,
I do think that there are certain indications, previously
discussed, which definitely offer a field for intravenous
anesthesia.

The old theories and practices of employ:ing

ether, hedon.sl,somnifaine, paraldehyde and isopral, are

'11

llflM•iiif
~

definitely outmoded, and although they once were used
fairly extensively with success, l believe that we can
dismiss them from the final analysis, as merely being of
historical value, and useless j_n the light of practical
present-day modes of producing anesthesia.
The next group of drugs of importance- can be
sunurn rize 1 under one heading; the use of barbiturates
intravenously.

My present belief is that the use of the

barbituric acid derivatives administered intravenously
promise to offer a worth-while adrii ti on to the armamentarium of +-he physician.

I doubt the adv1:1ntar-;e to the

surgeon of the use of thrise derivatives which result
in many hours or days of depression.

I believe that the

use of the quickly detoxified barbiturates do slip-,htly
constitute, a very valuable background upon which to
superimpose general anesthesia.

None of the barbituric

acid derivatives, at present available, appears to be
a true anesthetic substance, and hence should not be
considered for the replacement of the well established
volatile and controllable anesthetic.
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